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 This research has revealed significant chemopreventive potential belonging to the 
planet’s most renewable and abundant plant source: amenity grasses.  The 
characterization results from Chapter 1 demonstrated the potential chemoprevention 
attributes of supina bluegrass and bermudagrass crude extracts linked to the extensive 
phenolic acid profiles of these amenity grasses.  In contrast to cereals, amenity grass 
phenolic extracts (AGPE) offer appreciable amounts of unbound/free ferulic acid that 
would be available for rapid in vivo absorption.  The literature has shown ferulic acid to 
be a highly available and health benefitting phenolic compound.  Chapter 1 in vitro 
studies demonstrated AGPE-induced antiproliferation and apoptotic induction capacities 
in HepG2 and Caco-2 carcinoma cell lines.  The in vitro chemopreventive influences 
were shown to be dependent upon AGPE species, extract fraction, dose, and cell line.  As 
with most natural systems, a significant gap in knowledge exists as to how such health 
promoting components modulate metabolism to maintain health.  Thus, the objective of 
Chapter 2 was to monitor the metabolic alterations attributed to supina bluegrass and 
bermudagrass phenolic treatments in human hepatocellular liver carcinoma cells, HepG2, 
using Fourier Transform mid infrared (FT-mIR) spectroscopy.  The FT-mIR 
!
metabolomic method was used to assess temporal changes in the biochemical fingerprint 
of treated and untreated HepG2 cells compared to resveratrol positive control treatments.  
The results from this study illustrate amenity grass nutraceutical targets within the HepG2 
metabolme compared to the documented biochemical influences of resveratrol.  As an 
outcome to this study, the impacts of nutraceutical stimuli on the biochemical fingerprint 
were further elucidated by analyzing the ability of phenolics to downregulate the 
oxidative nature of cancer. 
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Chapter 1 
 
Characterizing the phenolic extracts of two natural products with 
extensive phenolic acid profiles (Cynodon dactylon and Poa 
supina) and their corresponding chemoprevention potential in vitro 
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LITERATURE REVIEW 
Nutraceuticals 
Stephen Defelice, the chairman of the Foundation for Innovation in Medicine 
(New York, NY), coined the term nutraceutical (nutrition-pharmaceutical) in 1989 
(Kalra, 2003).  Currently, there is not a generally accepted definition for the term 
nutracteutical, and it is often synonymous with the term ‘functional food.’  In a 1999 
policy paper, Zeisel distinguished whole foods from natural bioactive food compounds of 
whole foods available in a non-food matrix by using the term ‘functional foods’ to 
describe the former and ‘nutraceuticals’ to describe the latter (Zeisel, 1999).  Under this 
more recent definition (which will be used in this context for the entirety of this graduate 
thesis), nutraceuticals refer to extractable natural compounds that provide medical or 
health benefits, including the prevention and/or treatment of disease.  The term 
nutraceutical does not currently have a regulatory definition.  Therefore, the U.S. Food 
and Drug Administration do not recognize the term ‘nutraceutical’ (Ameye & Chee, 
2006).  Although, public health officials do agree that nutraceutical development is a 
viable means to maintain health and defend against nutritionally induced acute and 
chronic diseases (Andlauer & Furst, 2002).  Nutraceuticals are generally recognized as 
functional ingredients sold as powders, pills, and other medicinal forms not generally 
associated with foods (Ameye & Chee, 2006). 
Nutraceutical and dietary guideline development primarily focuses on reducing 
four related chronic degenerative diseases.  Specifically, heart diseases, cancer, type II 
diabetes and obesity are metabolic disorders with interrelated impairments in both 
cellular processes and metabolism, yet each disease also retains unique pathological 
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qualities (Thompson & Thompson, 2010).  For decades cardiovascular disease (CVD) 
has been the leading cause of morbidity and mortality worldwide (Massaro, Scoditti, & 
Annun, 2010).  By the end of 2010 though, cancer is expected to surpass CVD to become 
the number one killer among the chronic diseases (Aggarwal et al., 2009).  Moreover, it 
is now reported that 90-95% of cancers are attributable to lifestyles, while only the 
remaining 5-10% can be attributed to genetics (Anand et al., 2008). 
Reactive Oxygen Species (ROS) and Oxidative Stress 
In spite of the human body’s extensive cellular antioxidant systems, oxidative 
damage from the deleterious effects of reactive oxygen species (ROS) inevitably occurs 
(Martin et al., 2008).  The clinical implications of severe cellular damage may lead to 
molecular injury causing aging, age-related degenerative diseases (Parkinson’s disease 
and arthritis), and all four primary chronic diseases (Valko et al., 2007).  Molecular 
damage from ROS is termed oxidative stress.  Causes of oxidative stress in humans 
include toxins, infections, hypoxia-ischemia, hyperglycemia, xenobiotics, 
hyperlipidemias, cancer, inflammation, immune reactions, and elevated metabolism 
(Mandelker, 2008).  A delicate balance between biological ROS and antioxidants in 
biological systems needs to be maintained for sufficient signal transduction, promotion of 
apoptosis, and regulation of immune responses (Castro & Freeman, 2001).  Normal levels 
of ROS allow optimal cell function and promote apoptosis (Martindale & Holbrook, 
2002), the preferred mechanism of cellular death.  However, elevated ROS levels may 
lead to oxidative stress that can result in numerous biological events (Mandelker, 2008), 
as illustrated in Figure 1.1.  Notable ROS mutagens include superoxide (O2-), hydrogen 
peroxide (H2O2), and hydroxyl radical (. OH).  As mentioned above, these ROS are 
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natural byproducts of metabolism, but they also represent the common mutagens 
produced by radiation (Ames, Shigenaga, & Hagen, 1999). 
Figure 1.1. Cellular fates and impacts of ROS (Avramov, 2009). 
!!!!!!!!!!!!!!!!!!!!!! !
Nutraceutical Antioxidants 
Oxidative stress caused by ROS in humans is a well-established physiological 
process intrinsically controlled by antioxidant systems (Martin et al., 2008).  Human cells 
are inherently provided with a formidable array of enzymatic antioxidants (Halliwell, 
1994; Ames, Shigenaga, & Hagen, 1999) that work to maintain redox homeostasis in the 
host.  Stress-induced oxidative imbalances can result from excessive generation of ROS 
or a deficiency in enzymatic antioxidants.  At this point, the surplus of cellular free 
radicals can initiate damaging oxidative chain reactions within tissues and can potentially 
lead to numerous pathological conditions.  Fortunately, these oxidative surpluses in the 
body can be modulated with dietary and/or supplementary nutraceutical antioxidants.  In 
general, antioxidants are loosely defined as compounds characterized by an ability to be 
oxidized in place of another present compound (Seifried et al., 2007).   
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Knowledge of antioxidant effects on human health has increased dramatically in 
recent decades with research into mechanisms, molecular targets and molecular 
interactions (American Institute of Cancer Research/World Cancer Research Fund., 
1997).  As a result, use of antioxidants in various forms of nutraceutical supplements has 
become widespread among US adults (Radimer et al., 2004).  Nutraceutical antioxidants 
include notable compounds such as vitamins C and E, !-carotene, and phenolic 
compounds, among other plant-derived compounds with documented biological 
protective roles (Sheerens, 2001).  Dietary antioxidants are often proposed as therapeutic 
agents to counteract oxidative damage and combat degenerative diseases such as cancer 
(Vitaglione et al, 2004).  Supplemental cellular antioxidants are intended to prevent ROS 
concentrations from reaching damaging cellular levels in high-risk individuals (Seifried 
et al., 2007).!!!
Phenolic Antioxidants 
Diets rich in plant-based foods are said to reduce incidence of degenerative 
diseases, largely due to the abundant phenolic concentrations that confer antioxidant 
potentials (Kitts, 2006).  Oxidative stress is believed to be a major mechanism involved 
in chronic degenerative diseases such as cancer and heart disease (Zhang et al., 2008).  
Phenolic compounds are often viable combatants of degenerative diseases due to their 
multiple biological effects such as antioxidant activity, antimutagenic activity, anti-
inflammatory action and antiallergic activity (Karakaya, 2004; Mandelker, 2008).  
Phenols exert antioxidant activity through various mechanisms of action including free 
radical scavenging and inhibition of ROS generation during normal cellular metabolism 
(Zhang et al., 2008; Seifried et al., 2007).  These antioxidant activities help reduce the 
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oxidative damage of lipids, proteins, and nucleic acids, which may thereby prevent cell 
damage and/or death (Steinmetz & Potter, 1991).   
Thousands of natural phenolics have been identified in edible plants (Scalbert & 
Williamson, 2000).  It is therefore currently difficult, if not impossible, to characterize 
the precise nature and fate of all ingested phenols, but it is feasible to determine the main 
classes of phenols consumed and the rendering foods (Scalbert & Williamson, 2000).  
The bioactivity of these compounds relies partially on the release of the phenols from the 
plant matrix during digestion (Zafrilla et al., 2001).  Additionally, phenolic glycosolation 
in vivo can also affect the bioavailability and solubility of phenols during absorption 
(Zafrilla et al., 2001).  From a practical standpoint, it is conceivable that a combination of 
nutraceutical phenolics may provide more beneficial health effects as compared to a 
nutraceutical phenolic compound in isolation (Xu et al., 2009).  A natural plant extract 
may contain numerous phenols in balanced proportions, which may demonstrate superior 
metabolic influences (Ray et al., 2004).  Numerous studies have reported the syngerstic 
effects of phenolic compounds in concert (Olsson et al., 2004; Seeram et al., 2005; Ray et 
al., 2004).  This underlines the importance of the natural product itself for nutraceutical 
development.  
Phenolic compounds primarily consist of phenolic acids, flavonoids, stilbenes, 
and lignans (Karakaya, 2004).  The chemical base for this diverse family of molecules is 
the phenol structure: a hydroxyl substitution on an aromatic ring (Wildman, 2001).  From 
this basic structure, larger and more complex phenolic compounds are synthesized to 
service a wide variety of plant processes.  Classification of phenolic compounds typically 
reflects the nature of a compound’s carbon skeleton and its corresponding oxidation state 
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(Beecher, 1999).  Phenolic monomers, dimers, oligomers and polymers are all widely 
found in nature, foods and drinks (Beecher, 1999). 
Phenolic acids (Figure 1.2) are low molecular weight compounds ubiquitously 
found in fruits, vegetables and cereals (Clifford, 1999).  The growing interest in phenolic 
acids is related to their reported antioxidant activities in vivo (Rice-Evans, Miller, & 
Paganga, 1996).  A review by Lafay & Gil-Izquierdo (2008) outlined the extensive 
bioavailability of phenolic acids.  Numerous dietary phenolic acid agylcones including 
gallic, caffeic, ferulic, coumaric and chlorogenic acids can be actively absorbed by the 
stomach (Konishi, Zhao, & Shimizu, 2006).  Caffeic and ferulic acid aglycones also 
reportedly have absorption potentials within the small intestine (Lafay & Gil-Izquierdo, 
2008).  Esterfication of phenolic acids has been shown to considerably decrease their 
bioavailability (Adam et al., 2002).  However, flavonoid cleavage by gut microflora to 
bioavailable phenolic acid products has also been documented in vivo (Manach, Mazur, 
& Scalbert, 2005).  
Despite being the most consumed polyphenolic compounds in the human diet, 
phenolic acids have not received a fraction of the attention and research as that expended 
on the flavonoid phenolic class (Mateos, Goya, & Bravo, 2006; Scalbert & Williamson, 
2000).  Increased phenolic acid intake is primarily driven by the global consumption of 
coffee, which is rich in chlorogenic acids (Karakaya, 2004).  The two main subclasses of 
phenolic acids are benzoic acid derivatives and cinnamic acid derivatives (Lafay & Gil-
Izquierdo, 2008).  Nutritionally notable benzoic acid derivatives include gallic, ellagic, 
protocatechuic, and 4-hydrobenzoic acid (Lafay & Gil-Izquierdo, 2008).  These benzoic-
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derived phenolic acids show limited distribution in foods, yet gallic acid is reported to 
have excellent bioavailability.    
Cinnamic acid derivatives make a significantly larger contribution to daily 
polyphenol intake than do benzoic acids or flavonoids.  Notable cinnamic acids include 
p-coumaric, caffeic, ferulic, and sinapinic acids (Solecka, 1997).  These derivatives are 
rarely free and are mainly bound or esterified to organic acids, sugars, lignin or lipids 
(Clifford, 1999).  Caffeic and quinic acids combine to form chlorogenic acid (5-
caffeoylquinic acid).  Chlorogenic acid is found in high concentrations within coffee and 
many fruits (Mateos, Goya, & Bravo, 2006).  Ferulic acid can be found free within 
tomatoes and beer, but is most abundant in cereal grains where it becomes cross-linked to 
cell wall lignins (Palmer et al., 2008; Mateos, Goya, & Bravo, 2006; Grabber & Lu, 
2007).  
Figure 1.2. Phenolic acid structures (Chrzanowski, Sempruch, & Spraw 2007). 
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Flavonoids 
Flavonoids are a class of polyphenolic compounds ubiquitous in 
photosynthesizing cells and widely found throughout the plant kingdom (Havsteen, 
1983).  Dietary flavonoids are regarded as potent antioxidants (Cook & Samman, 1996) 
and facilitate numerous biological events in humans such as free radical scavenging, 
metal chelation, modulation of enzymatic activity, inhibition of cellular proliferation, and 
alteration of signal transduction pathways (Bravo, 1998; Cushnie & Lamb, 2005).  Diets 
rich in polyphenolics have been shown to reduce oxidative damage to DNA, thus 
preventing mutagenesis-linked carcinogenesis (Meyskens & Szabo, 2005; Zhang et al., 
2008).  An overwhelming body of evidence suggests that flavonoids may be health 
promoting dietary compounds (Middleton, 1996) that reduce the risk of chronic human 
diseases (Zhang et al., 2008; Martin et al., 2008; Beecher, 1999).  Furthermore, global 
interest in the antimicrobial properties of flavonoids has occurred in view of the recent 
string of drug resistant bacterial infections, such as MRSA (Cushnie & Lamb, 2005).      
Thousands of flavonoids have been identified in nature and hundreds of these 
have been reported in average human diets (Loke et al., 2008).  Flavonoids can be found 
in fruit, vegetables, herbs, grasses, grains, nuts, seeds, stems, leaves, roots, and flowers, 
as well as, tea, coffee, cola, cocoa, wine, beer, spices, honey, bacteria and algae (Cushnie 
& Lamb, 2005; Fan et al., 2011; Kulkarni et al., 2006; Aggarwal et al., 2009).  In the 
United States, it is estimated that average daily flavonoid intake ranges from 500-1000 
mg per day, but this estimate can be much higher for people with herbal rich diets 
(Skibola & Smith, 2000).  
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For such a vast group of compounds with relatively homogenous structure, 
flavonoids display an extensive range of biological activities (Cushnie & Lamb, 2005). 
While simple phenolic acid precursors result from the shikimic pathway, synthesis of 
polyphenolic compounds requires participation from the malonic acid pathway 
(Wildman, 2001).  It is well accepted that slight differences in flavonoid structural 
properties affect their bioavailability for intestinal absorption, as well as their formation 
and occurrence in blood plasma (Harbaum et al., 2008).  Among the major subclasses of 
dietary flavonoids (Figure 1.3) are the flavonols, proanthocyanidins (including 
catechins), isoflavonoids, flavones, and flavanones (Skibola & Smith, 2000; Wildman, 
2001; Harborne, 1988).  The basic flavonoid structure consists of the diphenylpropane 
skeleton (C6-C3-C6) with various hydroxylation, alkylation and methylation substitutions 
(Karakaya, 2004).  The presence and arrangements of these substitutions are important 
indicators for health-benefitting phytoactivities and are also used to distinguish between 
flavonoid subclasses (Figure 1.3).  
 
Figure 1.3.  Family of major dietary flavonoid groups (Skibola & Smith, 2000) 
!
!
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Lignin-bound Phenolics 
Lignin is a polymer of cross-linked phenolics that is an integral component of 
secondary cell walls in plants  (Boerjan & Baucher, 2003; Raes et al., 2003; Sarath et al., 
2006).  After cellulose, lignin is the most abundant organic molecule in plants and often 
classified as a fiber because it is not readily bioavailable to humans (Wildman, 2001).  
Phenolic compounds are present in free, as well as lignin-bound cell wall compounds 
(Harbaum et al., 2008).  Plants have the capacity to incorporate a range of bound phenolic 
compounds into their lignin matrix (Palmer et al., 2008; Clifford, 1999).  In particular, 
grasses can contain significant amounts of phenolic acids cross-linked to ester and ether 
linkages in the lignin matrix (Palmer et al., 2008; Clifford, 1999).  This is most likely due 
to the extensive lignification in grass secondary and primary cell walls.  Many of these 
lignin-bound phenolics can become bioavailable after cleavage by intestinal bacteria 
(Milder et al., 2005; Manach, Mazur, & Scalbert, 2005).  These previously bound 
phenolics reportedly have increased intenstinal absorption potentials and have been 
implicated in risk reduction of cardiovascular diseases and specific cancers (Kuijsten., 
2005; Milder et al., 2005).  Several studies have reported the enhanced antioxidant 
potentials of bound phenolic compounds compared to their free phenolic constituents 
(Harbaum et al. 2008). 
The growing interest surrounding the health benefits of lignin-bound phenolic 
acids is supported by a number of recent studies.  Bound phenolic acids from beer have 
been linked to a decreased risk of specific degenerative diseases (Szwajgier, Pielecki, & 
Targonski, 2005b).  Harbaum et al. (2008) reported the occurrence and benefits of bound 
phenolic acids from chinese cabbage.  Grains, such as soft wheat (Moore et al., 2005), are 
a prime host of bound phenolics.  Moore et al. (2005) reported significant amounts of 
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bound ferulic acid in wheat grains that displayed potential for release by the gut 
microbiota in vivo.   However, only limited data exists regarding bound phenolic 
investigations within various plant species.  More research is needed to better understand 
the antioxidant potential of these bound phenolic compounds.  Naturally, plants and 
grains with extensive cell wall lignification should prove to be viable options for future 
bound phenolic research.!!
Resveratrol 
 Stilbenes constitute a relatively small class of phenolic compounds and their 
structures consist of two aromatic rings connected by a two carbon methylene bridge 
(Pezzuto, Kondratyuk, & Shalaev, 2006).  Resveratrol, a natural phenolic phytochemical 
most notably derived from grapes and wine, is the most extensively studied stilbene.  
Epidemiological studies have demonstrated that red wine consumption is linked to lower 
incidences of cardiovascular diseases (CVD) (Kraft et al., 2009).  This phenomena is 
recognized as the French Paradox, which describes how the French suffer less from 
CVD compared to other industrialized nations despite diets rich in saturated fats 
(Richard, 1987).  The biological activity of resveratrol was first recognized by Siemann 
and Creasy (1992).  The chemopreventive properties of resveratrol have since been 
studied extensively and were first reported by Jang et al., 1997.  Resveratrol has 
displayed profound chemopreventive properties within all three of the general stages of 
carcinogenesis (Surh, 1999; Jang et al., 1997; Lee, Zhang, & Sanderson, 2008).  
Additionally, resveratrol has been shown to induce apoptosis at higher concentrations, yet 
distinct metabolic influences have been reported at lower concentrations (Lee, Zhang, & 
Sanderson, 2008; Kraft et al., 2009).  Resveratrol chemoprevention has been studied 
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extensively in an array of in vitro models including breast, prostate, leukemic, melanoma, 
lung, liver, and colonic cell lines [reviewed in: (Aggarwal et al., 2004; De la Lastra & 
Villegas, 2005)].  
Cancer and Chemoprevention 
Cancer is a complicated disease that manifests itself over a period of years.  
According to Seifried et al, (2007), “Cancer can be viewed as a number of distinct 
diseases, each defined by different genetic lesions, with certain characteristics shared by 
most cancers and cancer typers.”  Generally, cancer progression begins when a normal 
cell is transformed through the activation of proto-oncogenes and the down-regulation of 
tumor suppression genes such as p53 (Aggarwal et al., 2009).  Transformed cells may 
then begin uncontrolled proliferation and eventually become insensitive to anti-growth 
signals (Aggarwal et al., 2009).  At this point, cells are able to evade apoptosis, which 
results in tumor formation and the self-sufficiency of disease progression (Aggarwal et 
al., 2009; McDougall et al., 2008).  Furthermore, as tumor progression continues, growth 
is aided by the formation of new blood vessels that provide nutrients to the developing 
tumor.  This event fuels tumor growth and supports tumor invasion into other tissues, 
resulting in metastasis (Aggarwal et al., 2009).  Unregulated and prolonged production of 
cellular ROS has been linked to the DNA mutations and modifications in gene expression 
leading to carcinogenesis (Mandelker, 2008).  Particularly, activation of signal 
transduction pathways AP-1 and NF-"B have been accredited to ROS, which leads to the 
transcription of genes involved in cell growth regulatory pathways (Mandelker, 2008).   
Cancer chemoprevention uses agents that impede progression, reverse, or inhibit 
carcinogenesis in healthy subjects, thus reducing their risk of developing an invasive or 
! $'!
clinically significant disease (Hail Jr, Cortes, Drake, & Spallholz, 2008).  Subsequently, 
an effective chemopreventive agent should intervene early in the carcinogenesis process 
to eliminate premalignant cells before they become malignant, or protect normal cells 
from mutations (Hail Jr, Cortes, Drake, & Spallholz, 2008).  There has been significant 
success within chemoprevention development in the last fifteen years that has correlated 
with decreases in certain cancer types (Kellog, Sigman, & Greenwald, 1999).  Yet, 
development of chemopreventive agents is still inefficient and slow (Zou et al., 2005).  
Therefore, the search for more bioactive and less toxic chemopreventive agents such as 
natural products has been an extremely active scientific pursuit (Wang et al., 2009; Zou et 
al., 2005).  Development of non-invasive cancer treatments is needed and often required 
because traditional cancer treatments are toxic to normal cells and often cause serious 
side effects (Wasser, 2002).  Desirable characteristics of chemopreventive agents include 
the following (Aziz, Kumar, & Ahmad, 2003): 
1. Little or no toxic effect in normal, healthy cells 
2. High efficacy against multiple tumor sites 
3. Suitable form for oral consumption 
4. Known mechanism of action 
5. Low cost to the consumer 
6. Acceptance by human population 
Natural bioactive products from plants, microorganisms, and marines have been 
deemed a desirable source of chemopreventive agents due to their low toxicity and 
increased biocompatibility (Wang et al., 2009; Zhu & Wu, 2009).  The documented 
bioactivities of phenolic compounds have been shown to prevent damage to lipids, 
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proteins, and nucleic acids, thereby protecting against cell damage and death (Zhang et 
al., 2008; Steinmetz & Potter, 1991).  It is well documented that phenolic-rich natural 
products demonstrate suppresive effects against carcinogenesis and mutagenesis 
(Karakaya, 2004; Kitts, 2006; Thompson et al., 2008), as well as the reduction of 
oxidative damage to DNA, thus preventing the onset of carcinogenesis (Murugan et al., 
2010; Lee, Zhang, & Sanderson, 2008; Zhang et al., 2008).  Phenolic antioxidants may 
also confer chemopreventive activities in vivo by terminating free radical chain reactions 
(Yu et al., 2002).  Free radical chain reaction damage can contribute to cell injury and 
death, accelerate the aging process, and further promote tumorigenesis (Wong, Li, & 
Stadlin, 1999; Yu et al., 2002).  Cancer and other degenerative diseases/conditions may 
be prevented or improved through phenolic antioxidant treatments (Merken & Beecher, 
2000; Neff, 1997; Yu et al., 2002).!!!!!! 
Apoptosis and Cancer 
The hallmark cellular indicators of carcinogenesis include genetic mutations, 
unregulated cell proliferation, and the down-regulation of apoptosis.  Apoptotic 
dysfunction is also a key component in numerous other diseases, so scientific attempts to 
manipulate this dysfunction has proved widely appealing (Mandelker, 2008; Murugan et 
al., 2010).  The entire mechanism determining cellular life and death is controlled 
through a convoluted regulatory process heavily impacted by oxidative stress 
(Mandelker, 2008).  The literature demonstrates that stress-induced changes to specific 
biological modulators can switch the cell death mechanism from apoptosis to necrosis 
(Susin, Zamzami, & Kroemer, 1998).  Hence, sustained oxidative stress often leads to 
inflammation and/or necrosis by means of genetic alterations (Haddad, 2002).  
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Carcinogenesis-linked DNA damage can arise from direct ROS interaction with DNA 
units or can be caused by reactive compounds generated by oxidized lipids (Seifried et 
al., 2007).    
Cell death inevitably occurs through either apoptosis or necrosis, with apoptosis 
being the preferred cellular death mechanism.  Although necrosis and apoptosis can result 
from the same oxidative stress, their death mechanisms are different (Halliwell, 1994).  
During apoptosis, cell death occurs voluntarily as a function of internal signaling, thus 
cascading apoptotic cells into a programmed dismantling.  This process externalizes 
phosphatidylserine (Mates & Sanchez-Jimenez, 2000), a plasma membrane constituent, 
which provokes cell removal by phagocytes to ensure minimal collateral damage to 
surrounding tissues (Logue & Martin, 2008).   
Apoptosis is marked by cell shrinkage, nuclear condensation, and DNA 
fragmentation that occurs without the release of inflammatory cytokines involved in 
necrotic inflammation (Murugan et al., 2010; Seifried et al., 2007; Mandelker, 2008). The 
activation of caspase proteases, members of the cysteine family, is believed to initiate the 
apoptotic cascade (Seifried et al., 2007; Murugan et al., 2010; Logue & Martin, 2008).  
Proteins within the Bcl-2 and NF-"B families regulate the activation of these caspase 
proteins (Logue & Martin, 2008; Murugan et al., 2010; Mandelker, 2008).  The Bcl-2 
proto-oncogene is unique in the way that it can inhibit apoptosis when expressed (Mates 
& Sanchez-Jimenez, 2000).  Bcl-2 proteins protect against apoptosis by blocking 
cytochrome c release, an essential apoptotic signaling event (Mates & Sanchez-Jimenez, 
2000).  The prosurvival NF-"B transcription factor also plays a decisive role in 
tumorigenesis, given its ability to control various genes involved in apoptosis (Sethi, 
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Sung, & Aggarwal, 2008; Murugan et al., 2010).  Activation of NF-"B enables the 
nuclear factor to translocate the nucleus and regulate anti-apoptotic gene expression 
(Aggarwal et al., 2009; Murugan et al., 2010).  Chemopreventive strategies that target 
apoptosis and the related signaling molecules are central in designing effective disease 
interventions (Murugan, et al., 2010; Shen & Tergaonkar, 2009).  Phenolic compounds 
such as resveratrol and the polyphenols from grapes and tea have been shown to 
selectively suppress cancer proliferation by inducing apoptosis through NF-"B regulation 
(Lee, Zhang, & Sanderson, 2008; Xu et al., 2009; Murugan, et al., 2010).   
Liver and Colon Cancer Models 
 Human liver carcinoma is the fifth most common cancer worldwide and most 
liver cancer patients die within a year of diagnosis (Llovet, 2003; Tan et al., 2009).  At 
present, the search for antitumor liver cancer drugs remains an active area of research 
(Tan et al., 2009).  Many liver cancer studies use HepG2 cell lines as in vitro models to 
investigate cytoxic treatment effects and alterations in cellular redox balances (Xu et al., 
2009).  Figure 1.4 illustrates the relationship between oxidative stress and chronic liver 
damage.  HepG2 cells retain many hepatocyte characteristics such as Phase I and II 
enzyme induction and metabolism of xenobiotics (Cai et al., 2009).   
Colorectal cancer is the second leading cause of cancer death in North America 
and Europe, as well as the fourth most common form of cancer worldwide (Boyle & 
Langman, 2000).  Many researchers have demonstrated the protective effects of 
phytochemicals in relation to colon cancer (Yi, Fischer, & Akoh, 2005).  Oxidative stress 
has been linked to a number of intestinal pathological conditions, thus it is important to 
assess novel protective mechanisms concerning the intestinal epithelium (Wijeratne, 
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Cuppett, & Schlegel, 2005).  One of the most widely accepted in vitro models for the 
intestinal lining is the human colon adenocarcinoma cell line, Caco-2.  Caco-2 cell lines 
display many of the same morphological and functional properties of in vivo intestinal 
epithelial cells and mucosa (Meunier et al., 1995).  Caco-2 cells in monolayer exhibit 
similar characteristics of the intestinal epithelium such as brush border microvilli, tight 
junctions, and dome formation (Wijeratne, Cuppett, & Schlegel, 2005).  
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Figure 1.4. Role of oxidative stress in the genesis of liver damage (Vitaglione et al., 2004). 
 
 
Phenolic Literature Summation 
 As I began reviewing the nutraceutical literature, I quickly became aware of the 
disparity between public perception and scientific evidence regarding phenolic 
antioxidants.  The scientific knowledge gained over the past 20-30 years concerning the 
role of oxidative stress in disease has most likely lead to public fear mongering and the 
corresponding demand for antioxidant supplements.  To compensate, it appears science 
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took an overtly reductionist approach to phenolic antioxidant research, thereby neglecting 
the possible secondary effects of phenolics in vivo.   
Recent research has illustrated that the primary health benefits achieved from 
phenolic antioxidant consumption are most likely derived from the modulating role 
phenolics play in disease signaling, rather than their cellular protective effects, per se.  
Thus, as many oxidative stress pundits are advocating, the public and researchers alike 
are often misguided in their rationale that ‘antioxidants’ inhibit the processes associated 
with ageing and disease (Hail Jr, Cortes, Drake, & Spallholz, 2008).  To summarize, 
phenolic antioxidants’ role in chemoprevention is not, in fact, driven by a direct 
antioxidant mode of action, but rather by their modulating impacts on health and disease. 
Nutraceutical Grasses 
Staple food crops corn, rice, wheat, beans and potatoes are globally consumed in 
large amounts on a daily basis.  As such, it should be recognized that these foods are the 
primary vehicle by which health-promoting chemicals are delivered to the human body 
(Thompson & Thompson, 2010).  Typical Western diets present a monopoly of the 
family Poaceae in the staple foods consumed (Thompson & Thompson, 2010).  The 
Poaceae, or grass family, is the world’s largest plant family and the most important to 
humans.  “Were it not for the grasses, civilization as we know it today would not exist” 
(Moore, 1960).  Of the staple food crops listed above, the cereal species corn, rice, and 
wheat are all members of the Poaceae family.  Yet, a comprehensive nutraceutical 
evaluation of the Poaceae family does not exist outside of the cereal grasses.   
Additional nutraceutical research on amenity grasses within the Poaceae family is 
limited to select epidemiologically related studies.  Bermudagrass (Cynodon dactylon) 
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has been used as an anti-diabetic agent in traditional Indian medicine (Kirtikar & Basu, 
1980).  More recent assessments of bermudagrass in modern medicine have further 
acknowledged anti-diabetic potential, as well as advantageous affects on high-density 
lipoproteins (HDL) levels for lessening coronary risks (Singh et al., 2007).  Aqueous 
bermudagrass extracts have been reported as anti-inflammatory, diuretic and anti-emetic 
agents (Ahmad et al., 1994).  Antiulcer properties have also been attributed to 
bermudagrass extracts used in rat studies (Patil et al., 2005).  Epidemiological insights 
have lead to the elucidation of anti-cancer properties possessed by Cymbopogon citrates 
or lemon grass (Suaeyun et al., 1997) and Sasa Senanensis or bamboo grass (Seki et al., 
2008).  Wheatgrass (Triticum aestivum) seedlings demonstrate various antioxidant 
qualities (Kulkarni et al., 2006) such as superoxide scavenging abilities (Peryt et al., 
1992) and inhibition of DNA oxidation (Falcioni et al., 2002).  Nonetheless, despite 
significant epidemiological indicators and research, the notion of researching grasses for 
human health has remained bottlenecked and erratic at best.  This lends the possibility 
that one of Earth’s most abundant resources for human benefit has been underutilized in 
modern medicine. 
The specific aim of this chapter was to characterize the antioxidant activities and 
in vitro cancer antiproliferation effects on HepG2 and Caco-2 cell lines in response to 
phenolic extracts of two amenity grass species.  Compositional analyses of amenity grass 
phenolic extracts were also included to speculate on the possible phenolic agents 
responsible for eliciting nutraceutical benefits.  The initial hypothesis for this research 
stated that select amenity grasses would display enhanced phenolic antioxidant capacities 
that could be of nutraceutical benefit.  The rationale behind this hypothesis stemmed from 
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the elevated phenolic biosynthesis abilities attributed to grasses as a function of satisfying 
the phenolic demands needed for extensive lignification to occur.       
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MATERIALS AND METHODS 
Seed Sources  
Supina bluegrass [Poa supina Schrad. ‘Supranova’] seed was generously 
provided by United Seed (Omaha, NE) and bermudagrass [Cynodon dactylon (L.) Pers. 
var. dactylon ‘Sovereign’] seed was purchased from Seeds West (Yuma, AZ).  
Grass Samples 
A preliminary screening of amenity grasses was conducted using a multitude of 
seeded grass species.  This screening lead to the selection of two grass species (a C3 and 
a C4 species) as a result of elevated antioxidant activities (ORAC assay).  The two grass 
species chosen included supina bluegrass [Poa supina Schrad. ‘Supranova’] and 
bermudagrass [Cynodon dactylon (L.) Pers. var. dactylon ‘Sovereign’].  Grasses were 
planted in May of 2010 and grown from seed in greenhouses at the University of 
Nebraska-Lincoln’s East Campus.  Supina bluegrass samples were maintained under 15 
hr ~ 30 °C max day / 9 hr ~ 17 °C min night growth conditions.  Bermudagrass samples 
were maintained under 17 hr ~ 34 °C max day / 8 hr ~ 20 °C min night growth conditions 
in a separate warm season greenhouse.  Relative humidity in the cool and warm season 
greenhouses ranged daily from 30-80% and 45-90% respectively.  Supplemental lighting 
was supplied with halide lamps (200 mol photons m-2 s-1) and soil mixtures consisted of 
34% peat, 31% perlite, 31% vermiculite and 4% screened topsoil, amended with 2 kg 
dolomite m-2.   Additionally, grasses were watered, fertilized (20-20-20 nutrient solution 
containing 200 ppm N) and trimmed as needed. 
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Collection and Extraction 
 Amenity grass sampling consisted of trimming and collecting the apical 1/3 
fraction of above ground tissue growth.  Preliminary data indicated no significant 
differences in phenolic concentrations or antioxidant activities between tissue fractions 
within the upper 2/3 of growth.  Grass samples were collected between 75-100 days of 
post-germination growth and sampling occurred at the same time of day to ensure 
metabolic and photoperiod consistency.  Sample collections were transferred directly to 
the lab for fresh weight (fw) extractions.  Additionally, blueberry samples (Michigan 
Summer Blueberries, S/N MSB136760) were purchased from the local market in 
September of 2010.  Blueberry samples were refrigerated for one day after purchase 
before extraction.  Both fresh grass and blueberry samples were briefly ground with a 
coffee grinder before phenolic extractions.  Blueberry samples for collection consisted of 
equal parts skin and pulp to replicate a dietary positive control.   
Cell wall phenolic extractions were carried out according to a modified procedure 
from Sarath et al. (2006).  Soluble free cell wall phenolics (Figure 1.5) were extracted 
twice (1:25 w/v) with 50% aqueous methanol (acidified to pH 5) followed by 50% 
aqueous acetone.  Each extraction was facilitated with 1 hr of mixing/vortexing and 
supernatants were pooled after centrifuging at 3000 g for 10 min.  Sample pellets 
(residues) were vacuum-dried for 24 hr at 50 °C to remove residual solvents.  Pooled 
supernatants were stored at -20 °C until drying or further testing.    
 Soluble bound cell wall phenolics were extracted from the vacuum-dried residues 
(Figure 1.5).  Residues were hydrolyzed with 2 M NaOH (1:10 w/v) for 4 hr at room 
temperature to release the soluble bound phenolic compounds.  The saponified solution 
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was acidified to a pH # 2 with 12 M HCl and the released phenolics were extracted thrice 
with ethyl acetate (1:1 v/v).  The organic phases were pooled and stored at -20 °C until 
drying or further testing.  A detailed flow chart for the phenolic extraction process is 
illustrated in Figure 1.5.  Cell wall bound phenolics for blueberry extracts were not 
determined because a comparison to grasses would not be relevant considering the 
differences in cell wall compositions.     
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Figure 1.5. Phenolic extraction procedure 
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Determination of Total Phenolics 
The Folin-Ciocalteu method was used to determine total phenolic levels of the 
crude extracts as described by Singleton & Rossi (1965).  Sample extract aliquots (100 
µL) were reacted with 100 µL of Folin-Ciocalteu reagent (Sigma, St. Louis, MO, USA) 
and 4.5 mL of nanopure water.  After 3 minutes of mixing, 0.3 mL of 2% (w/v) sodium 
carbonate was added and samples were subsequently incubated at 25 °C for 2 hr with 
intermittent shaking and venting.  Detection of the phenolic compounds was achieved 
using a Beckman Coulter DU 800 Spectrophotometer (Fullerton, CA) set at wavelength 
760 nm.  Gallic acid in methanol (MeOH) served as the standard and total phenolics were 
expressed as mg gallic acid equivalents (GAE) g-1 fresh weight (fw) tissue. 
Determination of Total Flavonoids  
To quantify total flavonoids, 125 µL sample extract aliquots were added to 37.5 
µL of 5 % (w/v) sodium nitrite and 0.625 mL of nanopure water according to Adom & 
Lui, (2002).  After 4-6 min of incubation, 75 µL of 10 % (w/v) aluminum chloride was 
added to the sample.  Following an additional 5-7 minute incubation, 0.25 mL of 1.0 M 
sodium hydroxide and 0.4 mL nanopure water were added to the sample.  The sample 
mixtures were vortexed to remove any precipitate and total flavonoids were detected at 
510 nm.  Catechin hydrate served as the standard and total flavonoids were expressed as 
mg catechin equivalents (CE) g-1 fw tissue. 
HPLC Analysis 
 Vacuum dried amenity grass phenolic extracts (AGPE) were dissolved in 100% 
MeOH and filtered through a 0.2 µm nylon membrane before analysis. A Vydak reversed 
phase, 5 $m C-18 column was used for separation.  Phenolic acid and flavonoid detection 
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was achieved using a Waters HPLC system (Franklin, MA, USA) with a photodiode 
array detector (2996), autosamplers (717plus), and Millenium32 monitoring software 
(version 4.0).  The analytical conditions were as follows: autosampler temperature, 8 °C; 
injection volume, 25 µL; detection, 200-400 nm; monitoring wavelength, 254 nm 
(flavonoids) and 340 nm (phenolic acids); flow rate, 1 mL min-1.  The mobile phases 
consisted of (A) 1% formic acid in deionized water and (B) 25% acetonitrile and 1% 
formic acid in deionized water.  A duel pumping system was used to form mobile phase 
gradients by varying the proportions of mobile phase A to B.  A 0-60 min mobile phase B 
elution (0-100%) and 60-65 min mobile phase A elution (0-100%) was used for detection 
and was followed by 65-70 min of isocratic mobile phase A.  The phenolic acids and 
flavonoids were indentified by matching their retention time to those of standards.  
Phenolic content percentages were expressed on the basis of a specific weight of 
crude/hydrolyzed extract.  
Oxygen Radical Absorbance Capacity (ORAC) 
The ORAC method was completed as described by Ou, Hampsch-Woodill, & 
Prior, (2001) to measure antioxidant activities of the sample extracts.  A stock solution of 
standard was prepared by dissolving 0.010 g of trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid)  in 10 mL of 75 mM potassium phosphate buffer, 
pH 7.4.  A 50-fold standard serial dilution and extract samples (dissolved in 50% aqueous 
MeOH) were prepared in 75 mM potassium phosphate buffer solution (pH 7.4), which 
also served as the blank.  A 25 µL aliquot of prepared extracts, blanks, and standard serial 
dilutions were added to their respective wells within a 96-well plate.   
! %,!
The fluorescent probe fluorescein (150 $L of 8.16 x 10-5 mM) in buffer solution 
(pH 7.4) was incubated with standards, samples and blanks for 10 min and shaking 
occurred for 3 min of incubation time.  Briefly, the reaction was activated by adding 25 
µL of 153 mM 2, 2’-azobis (2-amidinopropane) hydrochloride (AAPH) after incubation.  
Specifically, AAPH generated peroxyl radicals oxidize fluoresceine, causing a decrease 
in fluorescence (excitation and emission wavelength of 485 nm and 520 nm respectively) 
that was measured every 1.5 min at 37 °C with a BMG Labtech FLUOstar Optima 
microplate reader (Durham, NC) until values plateau.  ORAC results were calculated 
using the area under the curve (AUC) differences between blanks and samples and 
expressed as µM trolox equivalents (TE) g-1 fw sample.  Higher ORAC values correlate 
with greater preventative peroxyl quenching activities. 
Cell Culture 
Human hepatocellular liver carcinoma (HepG2) and human colon carcinoma 
(Caco-2) cell lines were chosen as model cancer lines.  These cell lines have been shown 
to be model mammalian systems for monitoring oxidative stress (Martin et al., 2008; 
Wijeratne et al., 2005).  Caco-2 cells provided by the American Type Culture Collection 
(ATCC) (Rockville, MD) were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 1.5 g L-1 sodium bicarbonate, 1% nonessential amino acid (NEAA), 
50 units mL-1 penicillin with 50 µg mL-1 streptomycin, 1% L-glutamine and 20% fetal 
bovine serum (FBS) according to Wijeratne and Cuppett, (2006).   
HepG2 cells were cultured in Modified Eagle Medium Eagle (MEME) (Sigma, 
St. Louis, MO, USA) supplemented with 2.2 g L-1 sodium bicarbonate, 11 mL L-1 
penicillin/streptomycin (50 units mL-1 penicillin with 50 µg mL-1 streptomycin), and 10% 
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FBS.  Both cell lines were grown in 75 cm2 culture flasks and maintained at 5% CO2, 
95% air at 37 °C using a CO2 water-jacketed incubator (Thermo Fisher Scientific Inc., 
Forma Series II 3110, Waltham, MA).  Cell populations were subcultured every 2-3 days 
after washing with 10x phosphate buffer saline (PBS) and trypsinization (EDTA).   
MTT Cell Viability Assay 
 Cell viability was determined through metabolism of MTT tetrazolium salt (3-
(4,5-dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide) by a mitochondrial enzyme 
(succinate dehydrogenase) of living cells into a colorimetric end product and evaluated 
using the MTT kit provided by ATCC (Manassas, VA).   After reaching ~80% 
confluence, 100 µL cultured cell aliquots in DMEM or MEME (3.5 x 106 cells mL-1) 
were briefly distributed to 96 well plates and incubated at 37 °C and 5% CO2 to form a 
partial monolayer.  After 24 hr, the medium was removed and refreshed with growth 
medium [0.1% dimethylsulphoxide (DMSO) according to Zhang et al. (2008)] containing 
phenolic treatments (500, 250, 125, 62, 31, or 15 µg/mL).  After 18 hr of treatment 
incubation, 10 µL of MTT reagent (0.1 mg/mL) was added to each well.  Cells were 
incubated with the MTT reagent for 2 hr before adding 100 µL of lysing buffer to each 
well and incubating for another 4 hr.  The colorimetric end product (crystallized purple 
formazan) was estimated by measuring the absorbance at 570 nm with a BMG Labtech 
FLUOstar Optima microplate reader (Durham, NC).  The cell viability percentage was 
assessed by comparing the average absorbance of treated cells with the corresponding 
absorbance of untreated cells.       
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Annexin V-FITC Apoptosis Induction Assay 
 The Annexin V-FITC Apoptosis Detection Kit (Sigma, St. Louis, MO, USA) was 
used to evaluate phospholipid externalization in the plasma membrane (Murugan et al., 
2010), an event typically associated with apoptosis.  When HepG2 cells reached ~80% 
confluence, 0.7 mL cultured cell aliquots in MEME (3.5 x 106 cells mL-1) were briefly 
distributed to 24 well plates and incubated at 37 °C and 5% CO2 to form a partial 
monolayer.  After 24 hr of incubation, the medium was removed and refreshed with 
growth medium [0.1% dimethylsulphoxide (DMSO) according to Zhang et al. (2008)] 
containing amenity grass phenolic treatments (500 µg/mL GAE) or resveratrol (125 
µg/mL).  After 18 hr of treatment incubation, the adherent cells were harvested after 
washing with ice-cold 10x PBS and trypsinization.  MEME was then added to harvested 
cells to deactivate the trypsin and the cell solutions were briefly centrifuged at 2000 rpm 
for 2 min (4 °C).  Finally, cells were washed with 10x PBS, centrifuged (2000 rpm, 2 
min, 4 °C), and resuspended in 1x binding buffer (500 µL aliquots).  For analysis with 
flow cytometry, cells were stained with annexin V-FITC (fluorescein isothiocyanate) and 
PI (propidium iodide) according to the manufacturer’s instructions.  The cells were then 
incubated in the dark for 15 min and analyzed using flow cytometry (BD FACSCalibur, 
Franklin Lakes, NJ) at an excitation of 488 nm and an emission wavelength of 525 nm 
for the annexin V-FITC and 575 nm for PI.  A special thanks to Danielle Shea and UNL’s 
Virology department for the flow cytometry instrumentation. 
Statistical Analysis 
All experiments were performed in triplicate using three subsamples within each 
of three total machine reps. Cell culture assays followed a randomized complete block 
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design blocking for replicates.  Results were analyzed using the Statistical Analysis 
Software (SAS) package (Cary, NC, USA).  UV-Vis, ORAC, and MTT results were 
interpreted using the one-way analysis of variance (ANOVA) and Tukey mean separation 
techniques to determine significant differences (p > 0.05). 
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RESULTS 
Total Phenolic Concentration (TPC) 
  TPC results, as determined by UV-Vis absorbance, reflect amenity grass phenolic 
extracts (AGPE) sampled between 75-100 days of post-germination growth.  The soluble 
free phenolic and flavonoid concentrations did not significantly differ between the 
grasses, but AGPE did surpass blueberry extracts in both soluble free phenolic and 
flavonoid concentration (Table 1.1).  A significantly greater concentration of cell wall 
bound phenolics (hydrolyzed fraction) was obtained for bermudagrass extracts, yet bound 
AGPE fractions exhibited similar total flavonoid levels.  
 
  
Soluble free 
(mg/100 g) 
Soluble bound 
(mg/100 g) 
 Phenolic Compositiona   
Supina bluegrass  442 ± 49 ab  89 ± 13 d 
Bermudagrass  589 ± 62 ab  442 ± 84 a 
Blueberry  495 ± 39 c --- 
 Flavonoid Compositionb   
Supina bluegrass  236 ± 24 b 90 ± 9.4 ad 
Bermudagrass  255 ± 23 b 123 ± 27 a 
Blueberry  149 ± 9.6 ac --- 
Table 1.1. Total phenolic concentrations of crude extracts; a Results expressed as milligrams of 
gallic acid equivalents (GAE) 100 grams-1 of fw sample. Data represented as mean ± SD (n=3).  
Means with the same letter are not significantly different (P # 0.05) according to Tukey’s HSD 
test. b Results expressed as milligrams of catechin equivalents (CE) 100 grams-1 of fw sample. 
Data represented as mean ± SD (n=3). Means with the same letter are not significantly different 
(P # 0.05) according to Tukey’s HSD test. Moisture content of grass tissues was determined to be 
!.84 for supina bluegrass and !.61 for bermudagrass samples. 
 
HPLC Analysis 
 The phenolic profiles (primarily phenolic acids) of crude AGPE were detected 
and reported at 340 nm using HPLC (Figure 1.6).  The phenolic acid compositions of 
AGPE were distinct among species and extract types, yet each of the soluble AGPE (A 
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and B) did display some notable similarities.  Vitamin C (more visible at lower 
wavelengths) and ferulic acid were apparent in significant quantities within each soluble 
AGPE.  Additionally, appreciable amounts of resveratrol were detected in soluble 
bermudagrass AGPE (B), which represents a unique amenity grass constituent.  The 
HPLC analysis of bound bermudagrass extracts (C) revealed a phenolic profile 
dominated solely by two phenolic acid compounds.  Interestingly, neither of these 
specific conjugates was detected in the soluble bermudagrass extract.  
 
 
 
Figure 1.6. HPLC analysis of crude AGPE at 340 nm: (A) Supina bluegrass soluble extract; (B) 
Bermudagrass soluble extract; (C) Bermudagrass bound/hydrolyzed extract. 
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Table 1.2. Peak identification and compound percentages of AGPE at 340 nm. Results represent 
means of triplicate analyses ± SD. Percent results expressed on the basis of a specific weight of 
crude/hydrolyzed extract; retention time (tr).  
 
Antioxidant Activity (ORAC) 
 The ORAC antioxidant activity assay measured the ability of crude phenolic 
extracts to scavenge peroxyl radicals.  The highest ORAC values (Figure 1.7) were 
produced by the free and bound bermudagrass phenolic extracts (103.52 and 91.37 µM 
TE gram-1 fw, respectively), which differed significantly from the free and bound supina 
bluegrass extracts (51.55 and 36.08 µM TE gram-1 fw, respectively), as well as the 
blueberry phenolic extracts (24.12 µM TE gram-1 fw).  With the exception of bound 
supina bluegrass extracts, all of the AGPE results for the ORAC assay were significantly 
higher than the blueberry phenolic extracts. 
Peak tr (min) Compound        % 
  (A) Supina bluegrass  
1 
2a 
2 
3.48 
31.6 
32.9 
Vitamin C 
 
 
3.69 ± 0.51 
3.32 ± 0.45 
23.6 ± 1.01 
3 38.8 Ferulic acid 30.9 ± 1.99 
3a 39.4  11.3 ± 0.27 
4 42.7  12.5 ± 0.13 
5 47.0  2.31 ± 0.17 
  (B) Bermudagrass  
1 3.48 Vitamin C 1.85 ± 0.28 
3 38.8 Ferulic Acid 6.25 ± 0.99 
3a 39.4  7.32 ± 1.12 
6 
7 
8 
41.5 
42.1 
45.1 
 
 
 
5.03 ± 0.61 
4.70 ± 0.06 
11.8 ± 0.73 
9 48.2  9.43 ± 0.21 
10 49.7  3.61 ± 0.11 
11 54.7 Resveratrol 3.95 ± 0.45 
12 56.3  9.29 ± 0.43 
12a 56.7  12.5 ± 0.36 
  (C) Bermudagrass bound  
2 32.9  26.6 ± 0.20 
13 37.3  59.8 ± 0.55 
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Figure 1.7. Oxygen Radical Absorbance Capacity (ORAC); Results expressed as µM of Trolox 
Equivalents (TE) per gram of fresh weight (fw) sample. Data represented as mean ± SE (n=3).  
Means with the same letter are not significantly different (P # 0.05) according to Tukey’s HSD 
test.  
 
MTT Cell Viability Assay 
 The mitochondrial activity of Caco-2 and HepG2 cancer cells demonstrated dose-
dependents responses to the AGPE and control treatments (Figure 1.8), although 
bioactivities significantly differed among treatments and cell lines.  The most significant 
suppression of Caco-2 mitochondrial activity (A) was exhibited by supina bluegrass 
treatments (EC50~85 µg ml-1 GAE) followed by bermudagrass treatments (EC50~230 µg 
ml-1 GAE).  EC50 values refer to the concentration of extract that causes 50% inhibition of 
mitochondrial activity.  Both AGPE treatments demonstrated lower Caco-2 EC50 values 
than the blueberry phenolic treatments.  In contrast to the Caco-2 assays, bermudagrass 
treatments demonstrated the greatest HepG2 suppression (C).  Significant suppression of 
!"
#!"
$%"
$"
#"
&"
'&"
(&"
)&"
*&"
+&&"
+'&"
!M
 T
ro
lo
x 
Eq
ui
va
le
nt
s (
TE
) g
-1
 fw
 S
am
pl
e"
Supina Free! Supina Bound! Bermudagrass Free! Bermudagrass Bound! Blueberry!
! &*!
HepG2 growth by bermudagrass extracts resulted for 250 and 500 µg ml-1 GAE 
treatments, whereas no significant mitochondrial suppression occurred for the supina 
bluegrass treatments at the same concentrations.  In general, the observed EC50 values 
were lower among Caco-2 cell populations compared to HepG2 for AGPE treatments. 
 Figure 1.8B represents Caco-2 mitochondrial inhibition by bermudagrass bound 
(hydrolyzed) fractions.  Bound bermudagrass phenolic extracts displayed inhibitory 
influences on mitochondrial activity at higher concentrations, but pro-growth influences 
were apparent at lower treatment concentrations.  It should also be noted that bound 
bermudagrass results (Caco-2) displayed the greatest variability among all treatments. 
Figure 1.8D displays the impacts of resveratrol, ascorbic acid (Vitamin C), and bound 
bermudagrass phenolic extracts on HepG2 growth.  A significant dose-dependent pro-
growth effect was produced by the ascorbic acid treatments, while both hydrolyzed 
bermudagrass and resveratrol treatments had negligible impacts on HepG2 activity.   
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Figure 1.8. Inhibition of Caco-2 and HepG2 cancer cell population growth by amenity grass 
phenolic extracts compared to phenolic and dietary positive controls.  The MTT assay was used 
to estimate viable cell populations after cell incubation with treatments for 18 hr.  Data expressed 
as mean ± SE (n=3) and data points displaying (*) are significantly different than the untreated 
control cells (100% viability) according to Tukey’s HSD test (!=.05).  
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Annexin V-FITC Apoptosis Assay 
 Untreated and treated HepG2 cell populations were stained with annexin V (AV) 
and propidium iodide (PI) and analyzed using flow cytometry (1.4 x 104 gated events).  
Stained cells were assigned to FACS display quadrants using a fluorescence-activated 
cell sorting histogram that corresponded with apoptotic expression (Figure 1.9).  
Untreated HepG2 cell populations (A) displayed high viability (89.5%) among harvested 
cells.  The dominant viability among untreated controls corresponded with an apoptotic 
shift among phenolic treatment populations.  None of the concentrated phenolic 
treatments significantly induced necrosis at the given time point, and the most drastic 
shift from viability amongst AGPE occurred in the 500 µg mL-1 supina bluegrass treated 
cells (C).  The largest percentage of late apoptotic cells (29.8%) resulted from the 500 µg 
mL-1 bermudagrass treatments (D) and HepG2 viablility (39.1% viable cells) was best 
maintained with 125 µg mL-1 resveratrol treatments.  
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Figure 1.9. Flow cytometry analysis of apoptotic induction in HepG2 cells. Untreated cells (A) 
and cells treated with 125 µg mL-1 resveratrol (B), 500 µg mL-1 supina bluegrass (C), and 500 µg 
mL-1 bermudagrass (D) were stained with annexin V and PI and analyzed using FACS fluorescent 
detection. Phenolic treatments were applied for 18 hr and quadrant results (gated percentages) are 
representative of three independent trials.  
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Figure 1.10. Apoptosis assay quadrant assignments 
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DISCUSSION 
The scientific literature has recently been inundated with publications that 
describe the phenolic antioxidant attributes within an array of potential nutraceutical 
foods.  This compilation of research has revealed a number of scientific facts concerning 
phenolic compounds for human health: 
1. Natural plant matrices and extracts contain numerous phenols in balanced 
proportions. These phenolic combinations have been shown to elicit superior 
metabolic influences compared to phenolic compounds in isolation (Liu, 2004; 
Olsson et al., 2004; Seeram et al., 2005; Ray et al., 2004).  
2. The plant matrix has a considerable impact on phenolic metabolism and 
absorption (Adam et al., 2002; Harbaum et al., 2008). 
3. The ability of phenols to defend against disease is primarily a result of modulating 
influences on disease processes (Murugan et al., 2010; Xu et al., 2009; Crozier, 
Jaganath, & Clifford, 2009).  Only fringe medicines still popularize the notion 
that antioxidants block or inhibit the processes associated with ageing and disease 
(Hail Jr et al., 2008). 
4. Natural product production limitations and the effects of physiologically 
unrealistic phenolic dosage recommendations should be taken into account before 
advocating the nutraceutical development of a natural product (Duthie, Gardner, 
& Kyle, 2003; Crozier, Jaganath, & Clifford, 2009). 
Future generations of phenolic research efforts must build off of these realities and 
incorporate progressive logic into their focus.  This study attempted to meet the terms of 
this statement by focusing on the chemoprevention attributes and practicality of the 
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natural product itself.  Using the understanding that amenity grasses are the most 
renewable and abundant plant resource on Earth, the objective of this project was to 
characterize the phenolic chemoprevention potential of two grass species rich in phenols, 
particularly phenolic acids.  
Despite the fact that phenolic acids are the most widely consumed phenolic 
compounds in the human diet, phenolic acids have received only a fraction of the 
research expended on flavonoids (Mateos, Goya, & Bravo, 2006; Scalbert & Williamson, 
2000).  In reality, flavonoid studies have displayed a number of uncertainties in terms of 
flavonoid consumption and health benefits, including pro-oxidant potentials (Dickancaite 
et al., 1998; Hail Jr et al., 2008; Skibola & Smith, 2000), erratic in vivo metabolism 
(Hollman et al., 1999; Scalbert & Williamson, 2000; Duthie, Gardner, & Kyle, 2003), 
and low levels of absorption (Williamson & Manach, 2005; Crespy et al., 1999).  For 
these reasons, this study emphasized the chemoprevention potential belonging to a 
phenolic acid-dominated plant matrix.   
The results showed that the phenolic concentrations and antioxidant activities of 
supina bluegrass and bermudagrass are comparable to other highly regarded natural 
products.  While TPC and ORAC results may be arbitrary to in vivo modes of action 
(corresponding to health benefits), these tests provide a phenolic signature or point of 
reference applicable to their nutraceutical potential.  HPLC analyses in this study showed 
that both AGPE species contained extensive phenolic acids, yet the compositions were 
distinct for each species.  Similarities between AGPE profiles included significant 
amounts of ferulic acid and vitamin C (which was much more apparent at 240 nm).  
Clinical studies investigating vitamin C and E benefits in isolation have often reported 
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inconclusive results (Appel, van Garderen-Hoetmer, & Woutersen, 1996).  This 
phenomenon may be explained by a lack of complementary phenols that provide 
synergistic effects (Xu et al., 2009).  The presence of appreciable amounts of vitamin C 
and phenolic acids in AGPE may provide evidence for nutraceutical attributes belonging 
to the synergistic effects of vitamins and phenols.      
Free ferulic acid (FA) has been shown to be readily absorbed in vivo and its 
bioavailability is not limited by intestinal and hepatic metabolism (Adam et al., 2002).  
The source and forms of FA ingested determine the overall FA bioavailabilty, however it 
has been demonstrated that other phenolic acids, such as caffeic and chlorogenic acid, are 
often metabolized into ferulic and isoferulic acid in the intestine (Lafay et al., 2006).  
Paquet, Clifford, & Williamson, (2008) reported that colonic absorption of FA can occur 
through a combination of mechanisms: passive transcellular diffusion and facilitated 
transport.  These absorption processes leave free FA and a small percentage of 
conjugated FA available for the liver and other tissues (Paquet, Clifford, & Williamson, 
2008).  Furthermore, the fractional availability of FA for tissues has been reported to be 
~50% of the absorbed dose (Adam, et al., 2002), which is quite substantial considering 
that quercetin was only reported to have an available dose absorbance of ~9% (Crespy et 
al., 1999). 
Additionally, Adam et al, (2002) reported that the release of esterfied FA from a 
complex matrix is most effective when FA is bound in the primary cell wall- this 
supports the nutraceutical potential of amenity grasses, which display extensive primary 
cell wall lignification.  This present study’s HPLC analysis of hydrolyzed bermudagrass 
extracts revealed a bound phenolic profile consisting solely of two phenolic acid 
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compounds.  These bound compounds were also shown to possess appreciable 
antioxidant capacities according to ORAC results- an attribute that should be emphasized 
considering the reported enhanced absorption potentials of bound phenols (Harbaum et 
al. 2008; McDougall et al., 2008). 
In view of the absorption potential for FA-rich natural products, this study 
focused on the chemoprevention attributes of AGPE using HepG2 and Caco-2 cancer 
lines.  Two of the essential alterations in cell physiology necessary for carcinogenesis and 
tumorigenesis are deregulated cell growth and suppression of apoptosis.  Because these 
two processes are central to tumor development, they present obvious targets for 
chemopreventive or therapeutic intervention (Evan & Vousden, 2001).  The MTT and 
annexin-V assays are two widely used methods that evaluate cell proliferation and 
apoptosis induction, respectively.   
Mcdougall et al, (2008) reported Caco-2 cell lines to be a physiologically relevant 
model for first-pass screening of chemoprevention compounds.  The MTT results for 
Caco-2 cell populations in this study monitored the inhibition of mitochondrial activity 
by AGPE and compared it to that of blueberry extracts (Figure 7).  Inhibition of Caco-2 
proliferation by berries is well-documented in the literature (Jensen et al., 2002; 
McDougall et al., 2008).  Our cell viability study demonstrated dose-dependent Caco-2 
mitochondrial activity suppression among each of the phenolic treatments.  The most 
prevalent and statistically significant suppression of mitochondrial activity occurred with 
crude supina bluegrass extracts.  It should also be noted that bound bermudagrass AGPE 
exhibited Caco-2 antiproliferation at higher concentrations, but a pronounced low-dose 
pro-growth effect was apparent at lower concentrations.  Physiologically relevant doses 
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of hydrolyzed phenolics would most likely fall into these lower concentration ranges.  
This report has outlined the in vitro antiproliferative influences of AGPE on Caco-2 
cancer cells according to the MTT assay.  Considering the global prevalence of colorectal 
cancer, preliminary evidence supporting potentially novel colorectal protective 
mechanisms should not be ignored.  
The HepG2 cell line is widely used as a model system for the liver.  
Characterization of phase I and phase II enzymes, as well as xenobiotic transporters have 
confirmed HepG2 cells as a suitable model for metabolic studies (Brandon et al., 2006).  
While intestinal absorption would invariably present the liver with metabolized AGPE 
products in vivo, some AGPE compound consistencies would be maintained in vitro 
considering free FA’s rapid absorption in the stomach and the intestinal absorption of 
free and glucuronidated FA (Olthof, Hollman, & Katan, 2001; Mateos, Goya, & Bravo, 
2006).  The HepG2 MTT results for this study revealed AGPE effects that contrasted the 
Caco-2 study.  In this study, HepG2 mitochondrial activity was significantly inhibited by 
bermudagrass phenolics, but not by supina bluegrass.  Additionally, hydrolyzed 
bermudagrass extracts had a null effect on HepG2 mitochondrial acitivity. 
Resveratrol and vitamin C were used as positive and negative controls for the 
HepG2 study, respectively.  Control treatment additions and omissions between cell lines 
were a reflection of dietary points of reference according to documented treatment 
impacts.  Additionally, adequate concentrations of bound supina bluegrass fractions were 
unable to be obtained for MTT assays.  Resveratrol was chosen as the positve HepG2 
control due to its highly-regarded chemopreventive potential and its extensive use in 
bioassay tumor models (Lee, Zhang, & Sanderson, 2008).  Conversely, vitamin C 
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(ascorbic acid) was used as a negative control for validation purposes.  Vitamin C in 
isolation has been shown to provide a protective effect to cells in vitro, thus allowing 
hepatic cells to further proliferation by regulating excessive oxidation (Yin, Kim, Moon, 
& Lee, 2005).  Our results were consistent with the literature, which demonstrated 
resveratrol’s negligible impact on HepG2 mitochondrial (Marcsek, Kocsis, Szende, & 
Tompa, 2007) and vitamin C’s pro-growth effects at elevated concentrations in vitro 
(Chen & Cederbaum, 1998).  
Cell cycle disruption is a prerequisite for apoptotic death (Hickman, 1992).  
Considering bermudagrass’ impact on HepG2 mitochondrial activity, bermudagrass 
extracts demonstrated the greatest percentage of late apoptotic induction (29.8%) 
according to the annexin V analysis.  In contrast, supina bluegrass and resveratrol 
treatments showed limited influences on mitochondrial activity, but considerable 
apoptotic shifts resulted.  Supina bluegrass extracts displayed the greatest percentage of 
early apoptotic induction (72.9%), while cells treated with resveratrol maintained the 
greatest percentage of viability (39.1%) among treatments.  The lesser extent of observed 
HepG2 apoptosis with resveratrol could be attributable to the physiological unrealistic 
resveratrol treatment concentration (~ 547 µM).  The elevated treatment concentration 
was intended to serve as a positive control for this apoptotic study, but it could have 
triggered a distinct xenobiotic response in HepG2 cells- thus, reducing the apoptotic 
response.  It has been reported in the literature that effective doses of resveratrol to 
induce tumor apoptosis may only range from 40 to 200 µM (Aggarwal & Shishodia, 
2006).  
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The lack of correlation between annexin V and MTT results for supina bluegrass 
and resveratrol could be explained by a number of occurrences.   Cell viability assays 
display some notable limitations and oversights in terms of extrapolating conclusive 
chemopreventive results.  For example, the MTT assay can be misleading if treatments 
affect intracellular activities other than mitochondrial respiration (Weyermann, 
Lochmann, & Zimmer, 2005), or if treatments are able to revert precancerous cells back 
to a healthy state without significantly affecting viability.  Additionally, apoptosis is an 
energy-dependent process that requires functioning mitochondria.  Thus, cell viability 
assays do not take into account the fact that necrosis would ensue once intracellular 
energy stores had been exhausted (Bradbury, Simmons, Slater, & Crouch, 2000).  While 
apoptosis assays complement the cell viability studies, the annexin V assay only 
measures whole cells and cannot be used to draw conclusions about the subsequent fate 
of the cells.  When drawing conclusions from the annexin V assay, it is important to 
remember that dying cells are engaged in a cascade of molecular events that are 
reversible until a first irreversible process takes place (Galuzzi & Kroemer, 2009). 
In conclusion, characterization results demonstrated the potential 
chemoprevention attributes of AGPE, which were confirmed in our preliminary in vitro 
studies.  The in vitro chemopreventive effects of AGPE were shown to be dependent 
upon AGPE species, extract fractions, doses, and cell lines.  Characterization results 
illustrated AGPE’s extensive phenolic acid profiles, which displayed major contributions 
from ferulic acid compounds.  The literature has shown ferulic acid to be a highly 
available and health benefitting compound.  In contrast to cereals, AGPE offer 
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appreciable amounts of unbound/free ferulic acid that would be available for rapid 
absorption.   
This research has revealed significant chemopreventive potential belonging to the 
planet’s most renewable and abundant plant source.  Future studies should focus on in 
vivo bioavailability and metabolism, influences on healthy tissues, and determine 
physiological relevant doses of AGPE.    
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Chapter 2 
 
Application of mid IR spectroscopy to monitor phenotypic 
responses in HepG2 cells treated with resveratrol and phenolic 
acid-rich amenity grass extracts 
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LITERATURE REVIEW 
Nutritional Genomics and Metabolomics 
 Nutritional genomics is a comprehensive approach for investigating the influence 
of diet and genetic variation as risk factors for chronic disease (Kaput et al., 2005).  It is 
well documented that genomic expressions can be regulated by, and dependent upon, 
nutrients, micronutrients, and phytochemicals found in foods and supplements (Kaput, et 
al., 2005).  In the past, the central dogma of molecular biology supported a unidirectional 
flow of information from gene to transcript to protein (Hollywood, Brison, & Goodacre, 
2006).  However, this concept has been proven false through elucidation of the dynamics 
involved in expression of genetic information.  Hollywood, Brison, & Goodacre (2006) 
adequately summarized the historical landscape of molecular biology in a recent review: 
“It is fair to comment that molecular biology has generally been bogged down by 
hypothetico-reductionist thinking where small parts of the jigsaw have been studied in 
isolation.” 
 Nutritional genomics has embraced the need for molecular reform by generating a 
resurgence of systems biology approaches to understand the complex interplay of genes 
and the environment.  This paradigm shift in the post-genomic era has primarily been 
facilitated by the integrative analyses of the ‘-omic’ disciplines (Hanash et al., 2002; 
Westerhoff & Palsson, 2004; Hollywood, Brison, & Goodacre, 2006).  While functional 
genomic approaches couple the analysis of gene products such as mRNA 
[transcriptomics (Baldwin, Crane, & Rice, 1999)] and proteins [proteomics (Santoni et 
al., 1998)], these methods do not adequately describe how these upstream processes 
correlate to biological funtion or phenotype (Fiehn et al., 2000).  Because it is known that 
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metabolic fluxes are not solely regulated by gene expression (ter Kuile & Westerhoff, 
2001), the study of the metabolome (metabolomics) provides information most closely 
related to the phenotype.  The metabolome has been generalized as the collection of low 
molecular weight molecules present in cells that participate in general metabolic 
reactions and are required for maintenance, growth, and normal cell function (Oliver et 
al., 2003).  The investigation of intracellular metabolites is a powerful asset for 
understanding complex biological systems, but an inclusive analysis of the complete set 
of intracellular metabolites is not yet achievable (Kim, et al., 2010). 
Metabolic Fingerprinting 
 One strategy for metabolomic analysis is metabolic fingerprinting, or rather a 
non-targeted approach to metabolite analysis.  Metabolic fingerprinting is the rapid 
classification of samples through high-throughput analyses, which provides a snapshot of 
the metabolic composition at a given time (Johnson et al., 2003).  The advantage of 
fingerprinting techniques is their rapidity, yet these techniques do not generally allow for 
specific metabolite information (Hollywood, Brison, & Goodacre, 2006).  For this reason, 
fingerprinting strategies do not involve generating quantitative data on a specific 
metabolite, or even a group of metabolites with similar chemistries or biological origin, 
as this requires more time consuming and invasive methodologies (Kim, et al., 2010).  In 
general, metabolic fingerprinting analyses utilize physiochemical techniques to measure 
alterations in biochemical pathways, provide screening for integrative nutrigenomic 
studies, and can serve as diagnostic tools (Fiehn, 2002). 
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FTIR Spectroscopy 
Fourier transform infrared spectroscopy (FTIR) is an ideal technique for high-
throughput metabolic fingerprinting (Johnson et al., 2003).  FTIR resolves the chemical 
profile of a sample by measuring the entire chemical spectrum through means of 
absorbance of specific wavenumbers of IR light (Baker et al., 2008).  These absorbance 
values relate to IR-induced vibrations of specific chemical bonds or functional groups.  
Specifically, IR absorbance depends on the atoms involved in the bond and the strength 
of the intermolecular interactions; thus, the combined chemical spectrum from molecules 
in a sample essentially creates an IR fingerprint for a specimen (Baker et al., 2008). 
 The primary region of interest for FTIR analysis of biological samples is in the 
mid-IR, which is defined as 4000-600 cm-1 (Dunn & Ellis, 2005).  Cellular constituents 
including carbohydrates, lipids, amino acids, and fatty acids, as well as proteins and 
polysaccharides can all be analyzed simultaneously in the mid-IR (Harrigan & Goodacre, 
2003).  FTIR band assignments for specific cellular constituents have been tentatively 
assigned to spectral windows of interest (Table 2.1) according integrative assessments of 
the literature (Walsh et al., 2007; Fabian et al., 2006; Naumann, 2001).  Shifts in the 
ratios and/or conformations of the biomolecules responsible for a FTIR spectral region 
gives rise to subtle changes in the corresponding peaks (i.e. shifts, shapes, and/or 
intensity) and are indicative of intracellular alterations (German et al., 2006; Gasparri & 
Muzio, 2003). 
 In general, FTIR spectroscopy is an established, yet constantly evolving technique 
that allows for rapid, non-invasive, highly reproducible, and reagentless analyses (Dunn 
& Ellis, 2005).  The availability of computerized FTIR instrumentation has improved the 
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signal-to-noise ratio and allowed for extensive data manipulation (Kong & Yu, 2007).  
Additionally, band narrowing methods, Fourier self-deconvolution, and second derivative 
manipulations have enriched IR spectra interpretations and provided the foundation for 
qualitative and quantitative assessments (Dong et al., 2002).  Second derivative spectral 
analyses enhance the resolution of overlapping IR bands in a spectrum and can allow for 
elucidation of secondary structures (Susi & Byler, 1983).  Popular statistical assessments 
of FTIR data include cluster analyses, such as principal component analysis (PCA) and 
hierarchical cluster analysis (HCA).  Multivariate techniques such as these are able to 
cluster analyze FTIR data according to co-expressed unique biochemical fingerprint 
constituents (Hollywood, Brison, & Goodacre, 2006).  Equipped with mathematical 
resolution enhancement techniques and various options for data analysis (Kong & Yu, 
2007), FTIR has become extremely useful for metabolic fingerprinting applications 
within the life sciences.  Specifically, FTIR applications for pathology include 
considerable options for disease detection, diagnosis, and treatment (Kim et al., 2010). 
Table 2.1. Tentative FTIR band assignments (adapted from Kim et al., 2010) 
spectra were obtained from available literatures26,45–48 and are
shown in Table 1. We attempted to collect the spectrum of
lopinavir at the maximum concentration used in this work
(30 mM); however, no infrared absorbance was seen and so no
FT-IR spectrum was recovered so this confirms that there was no
direct contribution of the drug to the spectra of cell solutions
(data not shown).
Due to the qualitative similarity and complexity of the spectra
from the two cell lines, a visible inspection of differences would
be very difficult and so an initial multivariate analysis was carried
out with PCA, as described above, to investigate basic biological
differences between the two different cell types. The resultant
PCA scores plots and loadings plots are shown in Fig. 2. As can
be seen in Fig. 2A and B, a clear separation between the two cell
types is observed, indicating a high feasibility for an investigation
of the inherent differences between the parent and E6 cells in
terms of their biochemistry. Since the control and transfected
cells are isogenic, and thus have the same genetic background,
the only difference between the two cell types is the presence of
the E6 oncogene and its protein. Therefore, this result from PCA
clearly illustrates that the metabolic fingerprinting approach has
great enough resolution to detect clear metabolic changes caused
Table 1 Tentative FT-IR band assignment for C33A cells
Wavenumber/cm!1 Assignment FT-IR vibrational modes
Protein
"3400 to "3300 Amide A Str. mode of N–H
"1690 to "1620 Amide I n(C]O)
"1590 to "1530 Amide II d(N–H) and n(C–N)
"1340 to "1240 Amide III
Nucleotide
"1225 PO2! (asymmetric phosphate)
"1080 PO2! (symmetric phosphate)
Lipid
"2924 and "2850 Membrane lipids Symmetric CH2 str.
mode of CH2 chains
"2958 and "2873 Membrane lipids Asymmetric CH3 str.
mode of CH3 end groups
"1746 C]O
"1463 CH2 bending
"1165 Ester CO–O–C str.
Carbohydrate
"1200 to "900 ns(C–O) coupled
to the d(C–O–H)
ns(C–O–C)
ns(C–O)
"1030 Sugar
(glycogen)
Fig. 2 PCA scores plots (A, B) from PC1 (44.9%), PC2 (31.1%) and PC3 (13.1%), and loadings plots (C: PC1), (D: PC2) extracted from scores plot (A)
showing the differences between the spectra of C33A parent and E6-transfected cells; red: parent cells, blue: E6 cells; first two letters indicate the type of
cells and the name of the drug, lopinavir, last number represents the drug concentrations (mM).
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FTIR and Cancer 
As many diseases are an outcome of metabolic disorders (including cancer), 
metabolomic approaches are being developed as a means to identify biomarkers for 
disease (Hollywood, Brison, & Goodacre, 2006).  In particular, FTIR spectroscopy 
allows researchers to monitor the different phases of conformational and functional 
changes (biomarkers) in complex biological systems including both tissue and cell 
cultures (Giambattista et al., 2010).  Therefore, the use of FTIR for the identification of 
biomarkers within disease processes can serve as a logical starting point for therapeutic 
intervention and drug discovery (Hollywood, Brison, & Goodacre, 2006). 
The detection of cancer biomarkers with FTIR has been recognized for its ability 
to provide various types of information on small structural changes of biologically 
important constituents during cancer development and progression (Takahashi et al., 
1999).  This stems from the fact that FTIR techniques not only possess the sensitivity to 
discriminate between normal and cancerous cells/tissues (Argov et al., 2004; Kim et al., 
2010), but also are able to monitor basic cancer processes such as changes in metabolite 
concentrations (Liu et al., 1999) and shifts in the secondary structures of biomolecules 
(Malins et al., 2004).  For example, the amide I band (1700-1600 cm-1) is almost entirely 
comprised of C=O stretch vibrations from peptide linkages, while the amide II band 
(1575-1480 cm-1) is derived mainly from in-plane N-H bending and C-N stretch 
vibrations (Kong & Yu, 2007).  Shifts in amide I or II peaks are indicative of alterations 
in protein secondary structures of intracellular proteins (Mantsch & Chapman, 1996).  
Although, it has been shown that the amide II band demonstrates much less protein 
conformational sensitivity than its amide I counterpart (Krimm & Bandekar, 1986).  
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Baker et al, (2008) suggested that shifts in the amide I region represent biomarkers for 
cancer aggressiveness that correlate to protein conformational changes.  Additionally, 
Fabian et al, (2006) used the amide II region to differentiate colorectal adenocarcinoma 
from non-cancerous tissue and Giambattista et al, (2010) related amide I shifts (!-helix) 
to increased molecular disorder and apoptosis induction. 
Phosphate bands are due to PO2- vibrational stretching and asymmetric stretching, 
which may be indicative of phosphorylated DNA components (Tobin et al., 2004; Walsh 
et al., 2007).  The phosphate bonds of interest for cancer researchers occur primarily in 
the nucleic acid region (1300-900 cm-1).  Lasch, Pacifico, & Diem (2002) suggested that 
increases in cell division and metabolic activity correlate to more pronounced PO2- bands 
of DNA, RNA, and phospholipids.  This occurrence is significant for the study of cancer 
considering cancerous cells exhibit higher divisional rates than non-cancerous precursor 
cells (Lasch et al., 2004).  Argov et al, (2002) confirmed this hypothesis by analyzing the 
phosphate band at ~1080 cm-1.  Diem, Boydston-White, & Chiriboga, (1999) proposed 
that the ‘observability’ of the DNA phosphate backbone band at ~970 cm-1 was a result 
the decondensation of nuclear DNA- an event consistent with cell division.  Furthermore, 
Giambattista et al, (2010) showed that UVB radiation-induced PO2- shifts at ~1244 cm-1 
correlated to apoptotic events in Jurkat cells. 
  FTIR analyses have also been able to monitor alterations in DNA absorbance 
linked to cancer progression and the opposed apoptosis phenomena.  Liu et al, (2001) 
reported an absorption decrease in the nucleic acid spectral region following apoptosis in 
leukaemic cells.  Using ATR-FTIR spectroscopy, Gasparri & Muzio, (2003) reported 
similar findings and postulated that the condensation of chromatin during apoptosis may 
! (+!
lead to significant increases in DNA visibility, thus decreasing the intensity of nucleic 
acid bands.  In contrast, evidence from the literature demonstrates FTIR’s ability to detect 
cancer associated DNA lesions.  Malins et al, (2004) reported substantial FTIR-
detectable modifications in the DNA base and backbone structures as normal tissues 
progress to a cancerous state.  DNA spectral regions of interest included ~1720 cm-1 
(C4=O stretching; thymine residues) and ~1606 cm-1 (NH2 bending and C=N stretching; 
adenine residues).  Additionally, the spectral vibrations from ~1700-1350 cm-1 and 
~1275-750 may be respectfully attributed to alterations in nucleotide base and backbone 
structures, which may relate to DNA conformational changes (Malins et al., 2003; 
Tsuboi, 1969).  Considering that conformational changes in DNA structure are expected 
to alter gene expression and the fidelity of transcription and replication (Turner, 2001), 
these shifts in the FTIR spectra may be strongly correlated to the onset of cancer. 
Tissue specific glycogen concentration shifts during the onset of carcinogenesis 
are well documented in the literature.  In many organs such as the colon (Rigas et al., 
1990) and lung (Yano et al., 1996), glycogen levels in cancerous cells are higher than 
compared to normal cells.  Yet, in organs such as the liver and cervix, glycogen levels are 
lower in cancer cells compared to the levels in corresponding normal cells (Sahu & 
Mordechai, 2005).  In many cancer tissues, the increase in energy demands equates to the 
accumulation of glycogen in cancerous tissue (Rigas et al., 1990).  However, it has been 
hypothesized that in organs such as the liver, where glucose and glycogen levels are 
naturally elevated, glycogen does not accumulate in cancerous tissues due to the high 
levels of naturally available energy (Takahashi et al., 1999).  Therefore, the FTIR 
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vibrational region with glycogen bond contributions (1185-900 cm-1) may be a region of 
interest for distinguishing between normal and cancerous cells. 
Finally, the lipid vibrational region (3010-2800 cm-1) has also been reported to be 
a potential biomarker for cancer (Walsh et al., 2007).  In a study using breast cancer 
tissue, Fabian et al, (2006) showed an increase in lipid-like material using FTIR that 
corresponded to cancer progression.  A summary of the aforementioned cancer biomarker 
evidence using FTIR is illustrated below in Table 2.2. 
 
 
Figure 2.2. Tentative FTIR bands relating to cancer. 
 
 
 
 
 
 
 
 
 
 
Absorption band/ 
stretch (cm-1) Assignment Region of influence Cancer speculation 
~2830-2930 Fatty acids (1) Lipids Fabian et al, (2006) suggested that cancerous 
breast tissues have more lipid-like materials than 
benign tissues.  
~1610-1680 Amide I Protein secondary structure; !-helix (1645-
1666 cm-1); "-sheets (1613-1637); Random 
coils (1637-1645); "-turns (1666-1682) 
Shifts in secondary structure are thought to be 
spectroscopic biomarkers indicating structural 
disorder or stability (Kong & Yu, 2007; 
Giambattista et al., 2010). 
~1500-1700 Amide I and II 
(2) 
Protein content Protein compositional shifts within the amide 
regions are proposed to be indicative of protein 
content as it relates to cancer aggressiveness 
(Baker et al., 2008). 
~1200-1500 Phospholipids and 
nucleotides (3) 
Phosphodiester deoxyribose backbone Conformational changes in the nucleotide region 
would be expected to alter gene expression and 
may correspond to cancer (Malins et al., 2003). 
Phosphodiester hydrolysis is also an important 
factor in DNA repair (Giambattista et al., 2010).  
~1234, 1080, 970 Phosphates PO2
- bonds It has been reported that PO2
- bond intensities and 
shifts can be linked to divisional activity. Cell 
division is increased in a cancerous state (Walsh 
et al., 2007; Lasch et al., 2004; Tobin et al., 2004; 
Argov et al., 2002).  
~900-1185 Polysaccharides 
(4) 
Glycogen bonds Cellular impacts on glycogen levels are reported 
to occur with cancer. This event has been 
outlined using FTIR in the glycogen bond 
spectral region (Takahashi, et al., 1999).  
!
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Figure 2.1. FTIR spectra; numbers correspond with assignment labels in Table 2.2. 
 
 
A significant gap in knowledge exists as to how health-promoting components of 
natural systems modulate metabolism to maintain health.  Thus, the objective of this 
study was to monitor the metabolic alterations attributed to amenity grass phenolic 
extracts in human hepatocellular liver carcinoma cells, HepG2, using Fourier transform 
infrared (FTIR) spectroscopy.  Recent research by the authors has demonstrated in vitro 
cancer antiproliferation and apoptotic induction capacities linked to phenolic extracts of 
understudied amenity grass species supina bluegrass [Poa supina Schrad. 'Supranova'] 
and bermudagrass [Cynodon dactylon (L.) Pers. var. dactylon 'Sovereign'].  The results of 
this study illustrate amenity grass nutraceutical targets within the HepG2 metabolome 
compared to the chemopreventive influences of resveratrol.  Resveratrol has documented 
chemopreventive impacts within all of the general stages of cancer progression (Lee, 
Zhang, & Sanderson, 2008).  To our knowledge, this is the first investigation into the 
metabolic influences of resveratrol or amenity grass phenolics, as it relates to cancer, 
using FTIR spectroscopy.  
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MATERIALS & METHODS 
Seed Sources 
Supina bluegrass [Poa supina Schrad. ‘Supranova’] seed was generously 
provided by United Seed (Omaha, NE) and bermudagrass [Cynodon dactylon (L.) Pers. 
var. dactylon ‘Sovereign’] seed was purchased from Seeds West (Yuma, AZ).  
Grass Samples 
The amenity grass species used for this study included supina bluegrass [Poa 
supina Schrad. ‘Supranova’] and bermudagrass [Cynodon dactylon (L.) Pers. var. 
dactylon ‘Sovereign’].  Grasses were planted in May of 2010 and grown from seed in 
greenhouses at the University of Nebraska-Lincoln’s East Campus.  Supina bluegrass 
samples were maintained under 15 hr ~ 30 °C max day / 9 hr ~ 17 °C min night growth 
conditions.  Bermudagrass samples were maintained under 17 hr ~ 34 °C max day / 8 hr 
~ 20 °C min night growth conditions in a separate warm season greenhouse.  Relative 
humidity in the cool and warm season greenhouses ranged daily from 30-80% and 45-
90% respectively.  Supplemental lighting was supplied with halide lamps (200 mol 
photons m-2 s-1) and soil mixtures consisted of 34% peat, 31% perlite, 31% vermiculite 
and 4% screened topsoil, amended with 2 kg dolomite m-2.   Additionally, grasses were 
watered, fertilized (20-20-20 nutrient solution containing 200 ppm N) and trimmed as 
needed. 
Phenolic Extraction  
Phenolic extractions were carried out according to a modified procedure from 
Sarath et al. (2006).  Soluble free cell wall phenolics were extracted twice (1:25 w/v) with 
50% aqueous methanol (acidified to pH 5) followed by 50% aqueous acetone.  Each 
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extraction was facilitated with 1 hr of mixing/vortexing and supernatants were pooled 
after centrifuging at 3000 g for 10 min.  Sample pellets (residues) were vacuum-dried for 
24 hr at 50 °C to remove residual solvents.  Pooled supernatants were stored at -20 °C 
until drying or further testing.    
Cell Culture 
Human hepatocellular liver carcinoma (HepG2) cell lines were chosen as a model 
cancer line.  HepG2 cells were cultured in Modified Eagle Medium Eagle (MEME) 
(Sigma, St. Louis, MO, USA) supplemented with 2.2 g L-1 sodium bicarbonate, 11 mL L-1 
penicillin/streptomycin (50 units mL-1 penicillin with 50 µg mL-1 streptomycin), and 10% 
fetal bovine serum (FBS).  Cell populations were grown in 75 cm2 culture flasks and 
maintained at 5% CO2, 95% air at 37 °C using a CO2 water-jacketed incubator (Thermo 
Fisher Scientific Inc., Forma Series II 3110, Waltham, MA).  HepG2 cell populations 
from culture flasks were subcultured every 2-3 days after washing with 10x phosphate 
buffer saline (PBS) and trypsinization. 
Sample Preparation 
 When HepG2 cell populations reached ~80% confluence, 0.7 mL cultured cell 
aliquots in MEME (3.5 x 106 cells mL-1) were briefly distributed to 24 well plates and 
incubated at 37 °C and 5% CO2 to form a partial monolayer.  After 24 hr of incubation, 
the medium was removed and refreshed with growth medium [0.1% dimethylsulphoxide 
(DMSO) according to Zhang et al. (2008)] containing either amenity grass phenolic 
treatments (500, 125, or 31 µg mL-1 GAE) or resveratrol [(500, 125, or 31 µg mL-1) 
Sigma, St. Louis, MO, USA].  After 18 hr of treatment incubation, the adherent cells 
were harvested after quenching metabolisms with ice-cold 10x PBS and trypsinization.  
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MEME (unsupplemented) was then added to harvested cells to deactivate the trypsin and 
the cell solutions were briefly centrifuged at 2000 rpm for 2 min (4 °C).  Finally, cells 
were washed with 1x PBS, centrifuged (2000 rpm, 2 min, 4 °C), and resuspended in 0.15 
mL of 1x PBS.  For FTIR spectroscopy, 35 µL of each sample were pipetted onto a zinc 
selenide (ZnSe) plate and dried under vacuum (10 Hg) for 20 min at 35 °C.    
FTIR Spectroscopy 
Temporal changes in the mid infrared (IR) spectra of treated HepG2 cell 
populations were evaluated by comparison to untreated HepG2 populations.  Specifically, 
BioWheel technology using a Bruker Equinox 55 FT-MIR equipped with a deuterated 
triglycine sulfate detector was used to acquire FTIR spectra.  Samples were applied to a 
ZnSe plate, which contained 15 sample windows.  FTIR spectra were recorded directly 
from the dried sample biofilms using the transmission mode.  HepG2 treatment samples 
were concentrated to an optical density of ~ 0.9 absorbance units at 600 nm prior to FTIR 
analysis to ensure high and consistent signal to noise ratios.  Each spectrum was recorded 
in the mid IR range (4000-500 cm-1), at a resolution of 4 cm-1, with 128 interferograms 
co-added, averaged, and apodized with the Blackman-Harris 3-Term function and then 
Fourier-transformed.   
Recording of spectra, data storage, and all other spectral manipulations were 
performed using the Bruker Opus 4.0 Software.  All spectra were independently and 
consistently baseline corrected, normalized to the amide I peak, and Fourier self-
deconvoluted before averaging and analyzing using spectral manipulations.  A total of 
178 spectra were collected and averaged to determine biological treatment averages at 
each treatment concentration and the grand means of each treatment over all 
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concentrations.  Culturing methods and sample plating techniques followed a randomized 
complete block design, which blocked for replicates.  FTIR spectral areas were monitored 
and compared to the control through hierarchal cluster analysis (Ward’s algorithim) and 
presented in the form of dendrograms. 
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RESULTS & DISCUSSION 
 
Previous research by the authors demonstrated HepG2 growth suppression and 
apoptosis induction capacities attributed to supina bluegrass and bermudagrass crude 
phenolic extracts in vitro.  It was proposed that the diverse phenolic profiles and elevated 
ferulic acid (FA) content of amenity grasses could potentially lend these natural products 
as novel candidates for chemoprevention development.  To further test this hypothesis, 
FTIR spectroscopy was implemented to evaluate the nutraceutical targets of amenity 
grass phenolic extracts (AGPE) within the HepG2 liver cancer cell line.  These results 
were compared to the metabolic influences of resveratrol- an extensively studied 
polyphenolic compound with documented chemopreventive impacts on a variety of cell 
models, including HepG2 (Surh, 1999; Jang et al., 1997; Lee, Zhang, & Sanderson, 
2008).   
Characterization of phase I/II enzymes, as well as xenobiotic transporters have 
confirmed HepG2 cells as a suitable model for metabolic studies (Brandon et al., 2006).  
Therefore, the FTIR results for HepG2 cells directly treated with AGPE may conceivably 
be extrapolated to the human situation.  Moreover, while intestinal absorption would 
invariably present the liver with metabolized AGPE products in vivo, some AGPE 
compound consistencies would be maintained in vitro considering the rapid absorption of 
free FA in the stomach and the intestinal absorption of free and glucuronidated FA 
(Olthof, Hollman, & Katan, 2001; Mateos, Goya, & Bravo, 2006). 
Figure 2.2 depicts the preprocessed zero-order (A) and corresponding second 
derivative (B) FTIR spectra for all HepG2 technical replicates used in this study.  These 
spectra represent three biological replicates of cells treated with 500, 125, or 31 µg mL-1 
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of the AGPE and resveratrol with each replicate analyzed three times via FTIR.  Of the 
108 total spectra generated, only three spectra were discarded before analysis due to 
inadequate absorbance.  The discarded spectra originated from the same HepG2 
biological replicate treated with 500 µg mL-1 bermudagrass extract.  The weak signals 
may have resulted from a lack of viable cells, which may have been due to excessive 
cytotoxicity within the cell population.  For the remaining 105 spectra, multivariate 
analyses were carried out with the vector-normalized zero order data analyzed using the 
second derivative spectra. 
To evaluate basic HepG2 biological differences attributed to phenolic treatment 
influences, an initial multivariate analysis was completed using a hierarchical clustering 
assessment (Ward’s algorithm).  Figure 2.3A illustrates the frequency ranges utilized for 
the cluster analyses.  These regions account for the mid-IR spectral windows of interest: 
CH stretching bonds from lipids (3000 to 2800 cm-1); amide I and II functional groups 
associated with proteins (1700-1500 cm-1); amide III/fatty acid/phosphate functional 
group combinations associated with DNA, nucleotides, and phospholipids (1500-1200 
cm-1); carbohydrates and the DNA/RNA phosphodiester backbone (1200-900 cm-1).  The 
heterogeneity/clustering of the technical reps are presented in Figure 2.3B.  Although the 
large numbers of replicates make this figure difficult to review, the elevated phenolic 
treatment concentrations clustered away from the untreated controls respective of dose 
and treatment type.  The occurrence of dose- and treatment-specific metabolic influences 
on HepG2 populations provided the level of confidence needed for analyses using the 
averages of biological replicates, as shown in Figure 2.4.  
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Figure 2.2. FTIR spectra obtained from 105 treated and untreated HepG2 replicates. A) 
Preprocessed zero-order spectra B) The corresponding preprocessed second derivative spectra. 
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Figure 2.3. Heterogeneity of HepG2 cells treated with either amenity grass phenolic extracts 
(500, 125, 31 µg mL-1 GAE) or resveratol (500, 125, 31 µg mL-1) compared to untreated HepG2 
controls. Cluster analyses were completed using Ward’s algorithm on vector-normalized zero 
order data that was analyzed using second derivative spectra. A) IR spectral regions used for 
cluster analyses B) Cluster analysis of all technical replicates corresponding to spectra in Figure 
2.2A. 
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 The multivariate analysis presented shows the clustering of treatment averages 
according to their co-expressed biochemical fingerprint.  Therefore, similar fingerprints 
would be representative of similar biological functions, while increases in heterogeneity 
relate to shifts in the metabolic status of the cell.  With this in mind, Figure 2.4 clearly 
displays treatment-induced metabolic alterations.  As was expected, the severity of the 
treatment impacts appeared to be dose- and treatment-dependent.  Most noteworthy, were 
the unique treatment-specific signatures on HepG2 biochemical constituents.  For 
example, the metabolic influences of 500 mg mL-1 bermudagrass treatments (BT) were 
similar to resveratrol’s influence at lower concentrations.  In contrast, the 500 $g mL-1 
supina bluegrass treatments (SBT) and resveratrol treatments (RT) resulted in more 
dramatic HepG2 metabolic alterations, but these alterations were specific to each of the 
treatments.  These results indicate that SBT, BT, and RT displayed appreciable HepG2 
bioactivities, yet the mechanisms of action appeared to be treatment- and concentration-
specific.  Additionally, the reported differences in AGPE bioactivity supported the 
chemoprevention idiosyncrasies of particular amenity grass species for distinct biological 
influences.  
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Figure 2.4. Heterogeneity of HepG2 cells treated with either AGPE (500, 125, 31 µg mL-1 
GAE) or resveratol (500, 125, 31 µg mL-1) compared to untreated HepG2 controls. The 
multivariate analysis was performed using the averages of vector-normalized zero order data that 
was analyzed using the second derivative spectra for each biological replicate. A) Averaged IR 
spectra used for cluster analysis; untreated control (blue), bermudagrass treatments (orange), 
supina bluegrass treatments (red), resveratrol treatments (green). B) Hierarchical cluster analysis 
(Ward’s algorithm). 
  
 
 Before evaluating the spectral profiles as they relate to the down-regulation of 
cancer, a better understanding of the influences and physiological relevance associated 
with various treatment concentrations was necessary.  Figure 2.5 illustrates the 
difference spectra of the preprocessed zero order data for supina bluegrass treated HepG2 
cells at each of the concentration levels minus the untreated HepG2 control spectra.  
!"
#$
%&
'(
#'
))
*
*+
*,
-*
.(
*$
/0
- **
!"
#$
%&
'(
#'
))
*
*+
*-
12
*.
(*
$
/0
- **
3
45
#"
'5
"&
*
**6
74
5#
78
*
9%
:;
4'
*<
8%
"(
#'
))
*
*+
*,
-*
.(
*$
/0
- **
9%
:;
4'
*<
8%
"(
#'
))
*
*+
*-
12
*.
(*
$
/0
- **
!"
#$
%&
'(
#'
))
*
*+
*2
==
*.
(*
$
/0
- **
>"
)?
"#
'5
#7
8*
+*
-1
2*
.(
*$
/0
- **
>"
)?
"#
'5
#7
8*
+*
,-
*.
(*
$
/0
- **
>"
)?
"#
'5
#7
8*
+*
2=
=*
.(
*$
/0
-*
*
9%
:;
4'
*<
8%
"(
#'
))
*
*+
*2
==
*.
(*
$
/0
- **
A!
B!
! *$!
Thus, respective peaks/valleys represent treatment-induced increases/decreases in 
vibrational bands for particular FTIR spectral constituents.  Band alterations may 
intuitively reflect compositional increases/decreases in total constituent levels within a 
sample, or they may also reflect structural/conformational shifts that impact bond 
torsions, which lead to band differentials.  For example, the onset of carcinogenesis 
induces an increase in free radical generation, which leads to the formation of lipid, 
protein, and DNA peroxidation products (Petibois & Deleris, 2006).  These peroxidation 
products from carcinogenesis may be associated with structural alterations, which are 
detectable by FTIR spectroscopy.    
In the lipid region (3000 to 2800 cm-1), which is primarily attributed to membrane 
lipids (Kim et al., 2010), band intensity spikes resulted for the 500 µg mL-1 supina 
bluegrass treatments (SBT).  Conversely, band decreases in the lipid region occurred for 
the lower concentrations of SBT.  This suggests that SBT elicited dose-dependent lipid 
influences on HepG2 cells compared to the untreated control group.  The occurrence of 
these contrasting results may be intimately linked to lipid peroxidation and apoptosis 
processes. 
 The lower concentrations of SBT displayed an overall decrease in HepG2 amide 
I/II protein band intensities (1700 to 1500 cm-1).  In contrast, the 500 µg mL-1 SBT 
displayed spectral qualities similar to the untreated control group except for the 
distinctive emergence of the ~1640-1610 cm-1 band.  This band spike corresponds to the 
"-sheet region within protein secondary structures (Bourassa et al., 2010).  Pathologies 
such as cancer have been shown to induce changes in the extent of hydrogen bonding 
among protein amide groups leading to conformational changes (Petibois & Deleris, 
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2006).  Therefore, the occurrence of treatment-induced alterations in the amide regions of 
carcinoma cells may be linked to the overall cancerous state of the cells/tissue.   
Within the phosphate and nucleotide region (1500-1200 cm-1), the lower SBT 
concentrations elicited HepG2 band spikes, while a decline in band intensities occurred 
for 500 µg mL-1 SBT.  Liu et al, (2001) reported decreases in band intensities within the 
nucleic acid spectral region following the onset of apoptosis in leukemic cells.  The band 
differentials for SBT within this spectral region may be intimately linked to HepG2 
nucleotide modifications at lower SBT concentrations and the onset of HepG2 apoptosis 
at the higher SBT concentration.   
Significant increases in HepG2 vibrational bands also occurred for the lower SBT 
concentrations within the polysaccharide/carbohydrate region (1190-900 cm-1).  Yet, the 
500 µg mL-1 SBT elicited negligible influences on HepG2 cells in this spectral region.  
Strong glucose and glycogen bands occur in this carbohydrate region, so band shifts may 
reflect alterations in cellular energy metabolism.  It has been reported that in organs such 
as the liver and cervix, glycogen levels are lower in cancer cells compared to the levels in 
corresponding normal cells (Sahu & Mordechai, 2005).  Further investigations are needed 
to determine whether this glycogen-related event is relevant to our SBT difference 
spectra results, or even to in vitro models in general. 
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Figure 2.5. Average FTIR differences of preprocessed zero order spectra for supina bluegrass 
treated HepG2 cells at A) 31 µg mL-1 B) 125 µg mL-1 C) 500 µg mL-1 GAE.  The contributions of 
the untreated control spectra have been subtracted from the supina bluegrass treatment (SBT) 
spectra at each concentration level. 
 
Figure 2.6 illustrates the spectra for bermudagrass treatments (BT) at each 
concentration level minus the control.  The BT difference spectra differed from SBT in 
that the two higher BT concentrations displayed the most qualitative similarities.  Within 
the lipid region, slight increases in HepG2 lipid vibrational bands occurred for the higher 
BT concentrations, while declines in band intensities were apparent for the 31 µg mL-1 
BT.  Difference spectra results for each BT concentration were relatively similar within 
the amide I/II region, except for one well-defined spectral inverse at ~1650 cm-1.  This 
inverse displayed a major band spike for the higher BT concentrations at ~1650 cm-1.  
The IR spectral band at ~1650 cm-1 has been attributed to !-helix protein secondary 
structures (Bourassa et al., 2010; Kong & Yu, 2007).  Giambattista et al, (2010) proposed 
that shifts within this region could serve as a ‘spectroscopic biomarker’ for structural 
disorder relating to apoptosis induction.  The details surrounding this amide shift in 
bermudagrass treated HepG2 cells needs to be further investigated.   
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Within the phosphate and nucleotide region, the higher BT concentrations were 
qualitatively similar to the HepG2 untreated control group.  Conversely, the difference 
spectra for the 31 µg mL-1 BT displayed a drastic spike in band intensities in the ~1300-
1200 cm-1 range.  This spectral region is comprised of protein (amide III) constituents and 
symmetrical stretching of phosphodiester groups associated with the DNA backbone 
(Kim et al., 2010).  Within the polysaccharide/carbohydrate region, an interesting dose-
dependent occurrence was also detected: 31 µg mL-1 BT demonstrated a decrease in 
HepG2 band intensities; 125 µg mL-1 BT displayed increases in band intensities; and 500 
µg mL-1 BT and the untreated control group demonstrated similar HepG2 band 
intensities.  Considering the previous report by the authors that demonstrated HepG2 
apoptosis induction at 500 µg mL-1 BT, these results offer an interesting perspective into 
treatment- and dose-dependent apoptotic effects within liver cancer cells.  
 
Figure 2.6. Average FTIR differences of preprocessed zero order spectra for bermudagrass 
treated HepG2 cells at A) 31 µg mL-1 B) 125 µg mL-1 C) 500 µg mL-1 GAE.  The contributions of 
the untreated control spectra have been subtracted from the bermudagrass treatment (BT) spectra 
at each concentration level. 
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 Resveratrol’s bioavailability and accumulation in the liver has been well 
documented (Vitrac et al., 2003; Goldberg, Yan, & Soleas, 2003) in addition to 
resveratrol’s chemopreventive influence in vitro using liver cancer models (Sun et al., 
2002; Delmas et al., 2000).  While most of the resveratrol results presented in Figure 2.7 
represent physiologically irrelevant doses, this study was more concerned with 
elucidating the reported biochemical mechanisms of resveratrol using FTIR spectroscopy.  
In contrast to the AGPE difference spectra, the concentration-dependent differences in 
response to HepG2 resveratrol treatments (RT) were predominately due to degrees of 
band intensity, rather than contrasting metabolic events.   
 Within the lipid region, the difference spectra for each of the RT concentrations 
displayed increases in HepG2 lipid bands- an event consistent with both of the 500 µg 
mL-1 AGPE treatments.  Resveratrol’s influence on the HepG2 amide I/II protein region 
was very similar to that of the bermudagrass treatments.  Given the qualitative nature of 
FTIR difference spectra, it is not clear whether the spectral similarities between 
resveratrol and bermudagrass in the amide region suggest similar influences (or a lack 
thereof) as compared to the untreated HepG2 control group.  What can be deducted from 
the amide results are the unique impacts on protein secondary structure displayed by 
supina bluegrass treated HepG2 cells. 
 While subtle band inconsistencies were exhibited between RT concentrations in 
the phosphate and nucleotide region, for the most part, the spectra were qualitatively 
similar to the untreated HepG2 controls.  The same cannot be said for RT in the 
polysaccharide/carbohydrate spectral region.  Glycogen vibrational bands have been 
reported to occur from ~1045-1015 cm-1 in cancer cells (Takahashi et al., 1999; Kim et 
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al., 2010; Petibois & Deleris, 2006).  Of the three RT concentrations, the 125 µg mL-1 RT 
was the only concentration with significant influence (intensity decrease) on the 
aforementioned glycogen band.  In contrast, the 500 µg mL-1 RT displayed remarkable 
influence on nearly every spectral region (except glycogen) within the 
polysaccharide/carbohydrate window.  These results indicate significant interaction with 
nucleotide backbones and/or carbohydrate polymers by resveratrol at excessive 
concentrations. 
 
Figure 2.7. Average FTIR differences of preprocessed zero order spectra for resveratrol treated 
HepG2 cells at A) 31 µg mL-1 B) 125 µg mL-1 C) 500 µg mL-1.  The contributions of the 
untreated control spectra have been subtracted from the resveratrol treatment (RT) spectra at each 
concentration level. 
  
The recent and rapid evolution in understanding the underlying molecular 
alterations associated with carcinogenesis offers the possibility of targeting specific 
malfunctioning molecules and pathways to attain more effective and rational cancer 
therapy (Neergheen et al., 2010).  Rational cancer therapy approaches should involve 
natural products/chemicals that are highly accessible, affordable, and selective toward 
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specific carcinogenic conditions.  A myriad of research over the past two decades has 
elucidated numerous underlying phenolic chemopreventive mechanisms, which range 
from inhibition/reversal of genotoxic alterations, suppression of proteases and cell 
proliferation, and modulation of apoptotic and signal transduction pathways (Chen & 
Kong, 2005; De Flora & Ferguson, 2005; Hwang et al., 2007).  Specifically, resveratrol 
has been shown to induce apoptosis (Lee, Zhang, & Sanderson, 2008), delay cell entry to 
mitosis (Delmas et al., 2000), and modulate growth factor induced signaling cascades (De 
Ledinghen et al., 2001) in liver cancer studies.   
 Using the breadth of reports in the literature of resveratrol’s mechanistic influence 
on liver cancer, the cluster analyses and difference spectra results listed above present 
some intriguing insights into the therapeutic/preventive potential of AGPE.  These 
preliminary FTIR results have shown mechanistically assorted chemopreventive potential 
for AGPE.  While the 500 µg mL-1 bermudagrass treatments demonstrated HepG2 
metabolic influences similar to the known chemoprevention agent resveratrol, supina 
bluegrass treatments displayed distinct metabolic influences.  Thus, supina bluegrass 
extracts could provide a mechanistic alternative and/or complement for liver cancer 
chemoprevention.  Not only do these results reveal the therapeutic idiosyncrasies 
associated with AGPE, but they also affirm the subjective importance of understanding 
the associated idiosyncratic nature of natural products, profiles, and compounds for 
disease treatment options.     
The ferulic acid-rich AGPE profiles may also confer potential selectivity toward 
liver cancer in vivo.  Free ferulic acid (FA) has been shown to be readily absorbed in vivo 
and its bioavailability is not limited by intestinal and hepatic metabolism (Adam et al., 
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2002).  Furthermore, the fractional availability of FA for tissues has been reported to be 
~50% of the absorbed dose (Adam, et al., 2002), which is quite substantial considering 
that quercetin was only reported to have an available dose absorbance of ~9% (Crespy et 
al., 1999).  In addition to the potential selectivity of nutraceutical amenity grasses, AGPE 
may also offer select advantages over phenolic compounds in isolation such as 
resveratrol.  Cancer therapy and prevention approaches have recently adopted the use of 
total plant extracts due to the synergistic effects displayed by natural phytochemical  
cocktails, which may intervene at multiple carcinogenic stages (Neergheen et al., 2010).  
It is well documented in the literature that natural plant extracts contain numerous 
phenols in balanced proportions, which may demonstrate superior metabolic influences 
(Ray et al., 2004).  A number of studies have reported the syngerstic effects of phenolic 
compounds in concert (Olsson et al., 2004; Seeram et al., 2005; Ray et al., 2004).!
 After assimilating the chemoprevention potential and unique novel qualities 
associated with AGPE concentrations, an evaluation of the relationship between phenolic 
metabolic influences and specific carcinogenic events was undertaken.  Thus, a visual 
assessment of second derivative spectra was employed to evaluate AGPE nutraceutical 
targets within the HepG2 metabolome compared to the chemopreventive influences of 
resveratrol.  This second derivative analysis only assessed the 500 µg mL-1 GAE amenity 
grass treatments and the 125 µg mL-1 resveratrol treatments.  While the 31 µg mL-1 
resveratrol treatments represent a concentration (~135 µM) near physiological relevance 
(Vitrac et al., 2003), the cluster analysis and difference spectra results showed the 
influence of the 31 µg mL-1 treatments to be consistent to that of the 125 µg mL-1 
resveratrol treatments.  Therefore, a visual analysis of the 125 µg mL-1 resveratrol spectra 
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offered more pronounced metabolic shifts, while still maintaining a concentration level 
that could extrapolate to in vivo situations.  As for the 500 µg mL-1 GAE supina bluegrass 
and bermudagrass treatments, these concentrations represented the greatest degree of 
HepG2 metabolic influence.  Moreover, AGPE concentrations are most likely overstated 
due to the crude nature of the extracts (lack of purity) and the colorimetric standard 
curve-based concentration estimations.  However, the limited characterization and the 
lack of purity associated with AGPE profiles make physiological relevance speculations 
difficult for this preliminary study.  Additionally, increasing the purity of crude AGPE 
may also diminish their synergistic contributions.   
 The onset of carcinogenesis is generally associated with increases in free radical 
generation, which ultimately lead to the formation of lipid, protein, and DNA 
peroxidation products.  Within the lipid region, a number of FTIR studies have 
established tissue-specific lipid biomarkers for cancer diagnostic purposes.  Most of these 
studies investigated quantitative changes in oxidized lipid bands induced by 
carcinogenesis (Petibois & Deleris, 2006).  The lipid region (~3100-2800 cm-1) is 
composed of membrane lipids consisting of symmetric CH2 (~2924, 2850 cm-1), 
asymmetric CH3 (~2958, 2873 cm-1), and symmetric CH (~3010 cm-1) vibrational bands 
(Kim et al., 2010; Petibois & Deleries, 2004).  Gasparri & Muzio, (2003) reported an 
increase in the CH2/CH3 ratio that correlated to the onset of apoptosis, but believed this 
event was related to cell growth and not specific to apoptosis.  In contrast, Tsuzuki et al, 
(2004) showed that treatment induced apoptosis in tumor cells can occur via lipid 
peroxidation.  This is concerning for this study considering the possibility of phenolic 
pro-oxidation.  Because these conflicts of interest could be encountered within the 
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contexts of our experimental design, a quantitative lipid analysis was not pursued.  
Furthermore, as detailed in Figure 2.8, the qualitative similarities between the HepG2 
treatment spectra in the lipid window suggest a lack of unique molecular targets in this 
spectral region. 
 
Figure 2.8. Second derivative FTIR spectra in the lipid region obtained from treated and 
untreated HepG2 treatment averages; 500 µg mL-1 GAE bermudagrass treatments (orange), 500 
µg mL-1 GAE supina bluegrass treatments (red), 125 µg mL-1 resveratrol treatments (green), and 
untreated controls (blue). 
  
The most sensitive mid IR region to protein secondary structural components was 
the amide I region (~1700-1600).  A second derivative analyses of the amide I region 
allows for the identification of secondary structures present in proteins (Kong & Yu, 
2007; Susi & Byler, 1983).  Knowing that pathologies such as cancer have been shown to 
induce conformational changes in protein amide groups (Petibois & Deleris, 2006), 
numerous studies have used shifts in the amide I region to successfully evaluate the 
biopotentials of cancerous and healthy cell/tissues (Baker et al., 2008; Fabian et al., 2006; 
Lasch et al., 2004).  Figure 2.9 illustrates the amide I protein region for phenolic treated 
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and untreated HepG2 cells.  A second derivative analysis of this region allows for the 
identification of !-helix (1645-1666 cm-1), "-sheet (1613-1633 cm-1), random coil (1633-
1645 cm-1), and "-turn (1670-1690 cm-1) protein secondary structures.   
In Figure 2.9, the most drastic shift in HepG2 protein secondary structure was 
detected for 500 $g mL-1 supina bluegrass treatments, while the resveratrol and 
bermudagrass treatments displayed remarkable consistency throughout the amide region.  
This occurrence was also confirmed by the difference spectra results (Figure 2.5).  In 
comparison to the untreated HepG2 controls, the 500 µg mL-1 GAE supina bluegrass 
treated cells displayed a dramatic conformational shift toward "-sheet structures.  On the 
contrary, the influences of bermudagrass (500 µg mL-1 GAE) and resveratrol (125 µg mL-
1) were more related to increases in alpha helical structures (Figure 2.6 & 2.7), rather 
than to the direct induction of conformational alterations.  Recent investigations in the 
literature have suggested that these conformational changes in the amide I region may be 
intimately related to apoptotic and necrotic processes. 
Using heat stressed Jurkat cells, Giambattista et al., (2011) noted a large spike in 
the !-sheet band (corresponding decline in the %-helix band) and concluded that this band 
appearance was a necrotic biomarker.  The Giambattista et al., (2011) paper stated that 
the "-sheet band spike in heat stressed cells was due to nucleotide carbonyl stretching and 
ring breathing modes.  The appearance of the "-sheet band in the Giambattista paper 
corresponded to annexin–V flow cytometry results that demonstrated high levels of 
necrosis.  In another study using HL60 cells, Gasparri & Muzio, (2003) identified 
necrotic cells by the appearance of a band shoulder at 1621 cm-1.  Though, Gasparri’s 
group reported that levels of !-helix and "-sheet structures were unaffected in both 
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apoptotic and necrotic cells.  As seen in Figure 2.9, the distinct emergence of the "-sheet 
band (encompassing the ~1621 cm-1 absorbance band) was evident in supina bluegrass 
(500 µg mL-1 GAE) treated HepG2 cells.  Upon further investigation into the appearance 
of this band in cellular systems, some inconsistencies were uncovered concerning the 
direct correlation between necrosis and "-sheet conformational shifts. 
Figure 2.9. Second derivative FTIR spectra in the amide I region obtained from treated and 
untreated HepG2 treatment averages; 500 µg mL-1 GAE bermudagrass treatments (orange), 500 
µg mL-1 GAE supina bluegrass treatments (red), 125 µg mL-1 resveratrol treatments (green), and 
untreated controls (blue). 
 
The activation of caspase proteases has been reported to initiate the apoptotic 
cascade (Seifried et al., 2007; Murugan et al., 2010; Logue & Martin, 2008).  Within this 
apoptotic cascade, caspase-activated DNase (CAD) is a key apoptotic protein that 
degrades DNA through the action of caspases (Uegaki et al., 2005).  Uegaki et al, (2005) 
was the first to demonstrate the spontaneous aggregation of CAD into amyloid fibrils in 
the presence of low pH and salt.  Analyses of the CAD domain structure have revealed a 
protein conformation consisting of one !-helix and a five stranded "-sheet (Orengo, 
Jones, & Thornton, 1994).  Moreover, structural analyses of CAD fibrils revealed not 
! α-helix!
! β-sheet!
" 
  β-turn!
     #!!!
"#$%&'!
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only cross-" structures, but also an !-helix structure; a unique secondary structure for 
amyloid fibrils (Uegaki et al., 2005).  These conformational properties are significant due 
to their possible relationship to the "-sheet shift in the 500 µg mL-1 supina bluegrass 
treated HepG2 cells.  In a previous study by the authors, HepG2 apoptosis, and not 
necrosis, was observed for 500 µg mL-1 supina bluegrass treatments using the annexin-V 
flow cytometry assay.  Thus, the appearance of the "-sheet band and the absence of !-
helix band reductions may be explained by CAD activation in HepG2 cells treated with 
the elevated supina bluegrass concentration.  It is postulated that the fibrillogenesis of 
CAD proteins may have been facilitated through the use of phosphate buffered saline 
(PBS) during the cell harvesting procedure and the subsequent dehydration of acidified 
(apoptotic characteristic) HepG2 samples before analysis.   
The opposed hypothesis generated for this present study compared to the 
investigations by Uegaki et al, (2005) and Gasparri and Muzio, (2003), could be a result 
of differences in cell models.  Likewise, the appearance of similar amide I 
conformational shifts could also reflect a progressed stage of cell death that may or may 
not be specific to apoptosis or necrosis.  Although necrosis and apoptosis can result from 
the same oxidative stress, their death mechanisms are different (Halliwell, 1994).  Dying 
cells are engaged in a cascade of molecular events that are reversible until a first 
irreversible process takes place (Galuzzi & Kroemer, 2009).  Knowing this, it is 
reasonable that apoptosis and necrosis may share certain spectroscopic biomarkers 
depending on the various stages of cell death.  Other recent studies have demonstrated the 
occurrence of protein unfolding events induced by polyphenolic ligand binding.  In a 
FTIR study analyzing bovine serum albumin (BSA) unfolding, Bourassa et al, (2010) 
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showed that polyphenol binding induced a major decrease in !-helix structure, which 
correlated to an increase in "-sheet structure.  For our present study, the "-sheet spikes 
were not suspected to be a result of protein unfolding because decreases in !-helix 
structure were not apparent.     
Nucleic acids and phosphates also exhibit significant mid IR vibrational bands 
within biological samples (Benedetti et al., 1997).  FTIR analyses enable the 
identification of carcinogenesis-associated conformational changes in nucleotide base and 
backbone structures (Malins et al., 2003).  Moreover, the onset of apoptosis in biological 
samples has been shown to affect the IR band intensities of nucleotide structures.  
Apoptosis is marked by cell shrinkage, nuclear condensation, and DNA fragmentation 
(Murugan et al., 2010; Seifried et al., 2007; Mandelker, 2008).  It has been proposed that 
chromatin condensation occurring during apoptosis may result in elevated DNA mid IR 
vibrational bands, thus resulting in only a partial visibility of the nucleic acid bands 
(Tobin et al., 2004; Gasparri & Muzio, 2003).  Many studies have reported band intensity 
decreases within the nucleic acid region following apoptosis (Mantsch & Chapman, 
1996; Giambattista et al., 2011).  Furthermore, other studies have reported increases in 
nucleic acid band intensities associated with necrotic cells (Chiriboga et al., 1998). 
The first nucleotide shift of interest occurred near the amide region at ~1715 cm-1 
and can be observed within the second derivative spectra presented in Figure 2.9.  Malins 
et al, (2003) attributed the ~1715 band to thymine residues (C4=O stretching) associated 
with DNA bases.  According to Figure 2.9, the 500 µg mL-1 supina bluegrass treatments 
elicited a distinct shift in the thymine band.  In the nucleotide region presented in Figure 
2.10A, a similar shift for all treatments occurred at ~1400 cm-1 band.  Giambattista et al, 
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(2011) reported that ~1400 cm-1 band shifts may be linked to alterations in the 
methylation state of amino acid side chains and fatty acids that corresponds to the 
progression of carcinogenesis.  The spectral shift at ~1237 cm-1 for supina bluegrass 
treated HepG2, which is presented in Figure 2.10B, is reportedly associated with 
conformational changes in the DNA sugar phosphate (PO2-) backbone (Malins et al., 
2004).  Malins’ group suggested that band shifts toward higher wavelengths within this 
phosphate absorbance peak were indicative of increasing tumor aggression in prostate 
tissues.  Therefore, the ~1237 cm-1 shift in the FTIR spectrum of supina bluegrass treated 
HepG2 cells may be linked to a decrease in carcinogenic aggression.   
In general, all of the treatments exerted various influences within the nucleic acid 
and phosphate spectral region.  Yet, the most drastic and distinct metabolic influences 
occurred for supina bluegrass treatments.  The difference spectra results presented in 
Figure 2.11 comparatively detail the overall decreases in band intensities for all 
treatments in the ~1500-1200 cm-1 spectral window.  As mentioned earlier, it has been 
reported that nucleic acid vibrational bands decline in intensity following apoptosis.  As 
compared to the untreated HepG2 controls, the most severe decrease in nucleic 
acid/phosphate vibrational bands resulted in response to the 500 µg mL-1 GAE supina 
bluegrass treatments- another factor supporting our hypothesis that the !-sheet shift of the 
SBT treated cells in the amide region was not necessarily correlated to the onset of 
necrosis. 
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Figure 2.10. Second derivative FTIR spectra in the nucleic acid and phosphate region obtained 
from treated and untreated HepG2 treatment averages; 500 µg mL-1 GAE bermudagrass 
treatments (orange), 500 µg mL-1 GAE supina bluegrass treatments (red), 125 µg mL-1 resveratrol 
treatments (green), and untreated controls (blue). 
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Figure 2.11. Average FTIR differences of preprocessed zero order spectra for treated HepG2 
cells at 500 µg mL-1 GAE bermudagrass treatments (orange), 500 µg mL-1 GAE supina bluegrass 
treatments (red), 125 µg mL-1 resveratrol treatments (green).  The contributions of the untreated 
control spectra have been subtracted from each treatment spectra and the results are presented in 
the nucleic acid and phosphate spectral window (~1500-1200 cm-1).       
 
 A number of potential cancer biomarkers in the polysaccharide and carbohydrate 
regions (~1200-900 cm-1) have been reported in the literature.  In Figure 2.12A, band 
alterations at ~1120 cm-1 were visible for all HepG2 treatments.  According to 
Giambattista et al, 2011, the ~1120 cm-1 vibrational peak is attributed to lactic acid.  
Increases in cellular lactic acid production (Warburg effect) are linked to overactive 
glycolysis, which can be associated with increased hypoxia in cancer cells (Weljie & 
Jirik, 2010).  The difference spectra presented in Figure 2.13 allows for a comparative 
analysis of HepG2 lactic acid concentrations among treatments.  At ~1120 cm-1, AGPE 
had negligible effects on lactic acid production, while the 125 µg mL-1 resveratrol 
treatments demonstrated a substantial decrease in the lactic acid band.  Hypoxia in cancer 
cells has been proposed to promote increases in cancer aggression and the onset of 
hypoxia has been shown to modulate a cellular shift away from oxidative 
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phosphorylation toward glycolysis (i.e. Warburg effect: increases in lactic acid 
production) (Weljie & Jirik, 2010).   
 Another band shift was detected at ~1088 cm-1 (Figure 2.12A).  This vibrational 
peak is associated with the symmetric phosphate bonds (PO2-) of DNA backbone 
components (Malins et al., 2003).  Each of the treatments induced a similar phosphate 
shift toward ~1090 cm-1.  Additionally, the difference spectra results in Figure 2.13 once 
again illustrated substantially less band intensities for resveratrol treated cells.  The 
absorption bands < ~1050 cm-1 are primarily attributed to ribose phosphate main chain 
vibrations (Malins et al., 2004) and glycogen/glucose bands (Kim et al., 2010; Takahashi 
et al., 1999).  As shown by Figure 2.12B, all treatments demonstrated considerable 
influence on HepG2 energy metabolism and nucleotide backbone components.  
According to the difference spectra results in Figure 2.13, the spectral trends were once 
again consistent for resveratrol and bermudagrass treatments, while a spectral inverse was 
apparent from ~1040-980 cm-1 for supina bluegrass treatments.  Malins et al, reported 
that the ~1020 cm-1 band is attributed to ribose phosphate main chain vibrations. 
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Figure 2.10. Second derivative FTIR spectra of the polysaccharide and carbohydrate and region 
(~1200-900 cm-1) obtained from treated and untreated HepG2 treatment averages; 500 µg mL-1 
GAE bermudagrass treatments (orange), 500 µg mL-1 GAE supina bluegrass treatments (red), 125 
µg mL-1 resveratrol treatments (green), and untreated controls (blue).  
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Figure 2.11. Average FTIR differences of preprocessed zero order spectra for treated HepG2 
cells at 500 µg mL-1 GAE bermudagrass treatments (orange), 500 µg mL-1 GAE supina bluegrass 
treatments (red), 125 µg mL-1 resveratrol treatments (green).  The contributions of the untreated 
control spectra have been subtracted from each treatment spectra and the results are presented in 
the carbohydrate spectral window (~1200-900 cm-1). 
 
 In conclusion, evidence has been presented to show the effects of crude amenity 
grass extracts on the biochemical fingerprint of HepG2 liver cancer cells in vitro.  These 
influences were evaluated for chemopreventive and chemotherapeutic biomarkers as 
compared to the known chemopreventive phenolic compound, resveratrol.  In addition to 
the therapeutic appeal associated with amenity grass nutraceuticals in terms of (i) 
elevated absorption and tissue selectivity, (ii) low cost to patients/consumers, (iii) global 
accessibility, (iv) inconsequential impacts on the global food supply; amenity grass 
nutraceuticals offer additional cancer specific advantages.  For example, the results 
presented above outline the novel qualities associated with the molecular targets of 
specific amenity grass species.  This could prove to be a key attribute for cheap and 
effective personalized medicines.  Additionally, the synergistic and interactive effects of 
natural phytochemical cocktails can provide combination therapies/prevention programs 
! ,$!
that simultaneously influence multiple molecular targets.  Furthermore, natural extracts 
may be able to achieve treatment efficacy beyond the reach of single compound-based 
drug by reducing toxicity potentials as lower doses of individual compounds within a 
cocktail can be administered (Neergheen et al., 2010). 
 Our results showed that FTIR spectroscopy is a viable tool for discriminating 
between molecular targets within cancer cells.  To our knowledge this is the first study to 
use FTIR spectroscopy to comparatively investigate the underlying mechanisms of action 
associated with natural chemopreventive agents.  Our results clearly demonstrated the 
nutraceutical properties of supina bluegrass and bermudagrass.  The molecular targets of 
bermudagrass (125 and 500 µg mL-1 GAE) were most similar to the documented impacts 
of resveratrol (31 and 125 µg mL-1).  In contrast, distinct molecular targets for supina 
bluegrass treatments (500 µg mL-1 GAE) were exhibited- especially on protein secondary 
structure.  Both bermudagrass and supina bluegrass treatments also affected nucleotide 
base and backbone structures.  According to Turner, (2001), the corresponding 
conformational changes would be expected to influence gene expression and the fidelity 
of transcription and replication.  However, it was not believed that the unique influences 
reported in supina bluegrass treated HepG2 cells were linked to necrosis.  Previous work 
by the authors demonstrated negligible HepG2 necrosis (annexin V assay) and 
cytotoxicity (MTT assay) associated with supina bluegrass treatments within the same 
concentration range.  It is conceivable that some of the unique shifts within the supina 
bluegrass spectra represent a progressed cellular stage of programmed dismantling (i.e. 
apoptosis). 
! ,%!
 Future investigations into the chemopreventive potential of amenity grasses 
should begin to address the physiological relevance of doses for in vivo testing and in 
vivo absorption and distribution.  Finally, additional studies are needed concerning the 
ability of amenity grasses to selectively target carcinogenesis without adversely 
impacting healthy tissues.  According to Weljie & Jirik, (2010), “The ability to 
preferentially target cancer cells without incurring significant toxicity to normal cells 
represents one of the ‘Holy Grails’ of cancer therapeutics.”  Natural phytochemical 
cocktails may be one of the most viable possibilities for realizing this highly sought-after 
therapeutic quality.      
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